Journal Watch

Immune glomerulopathies

The investigative burden of membranous nephropathy in the UK.
Author(s): Hamilton P, Wilson F, Chinnadurai R, Sinha S, Singh M, Ponnusamy A, Hall P, Dhaygude A, Kanigicherla D, Brenchley P
Source: Clin Kidney J 2020 Feb;13(1):27-34
Publication date: 2020-02
Socioeconomic Position and Incidence of Glomerular Diseases.
Author(s): Canney M, Induruwage D, Sahota A, McCrory C, Hladunewich MA, Gill J, Barbour SJ
Source: Clin J Am Soc Nephrol 2020 Feb 20;
Publication date: 2020-02-20
Genome-wide assessment of genetic risk for systemic lupus erythematosus and disease severity.
Author(s): Chen L, Wang YF, Liu L, Bielowka A, Ahmed R, Zhang H, Tombleson P, Roberts AL, Odhams CA, Cunninghame Graham DS, Zhang X, Yang W, Vyse TJ, Morris DL
Source: Hum Mol Genet 2020 Feb 20;
Publication date: 2020-02-20
Oxidative stress, inflammation and disease activity biomarkers in lupus nephropathy.
Author(s): Bona N, Pezzarini E, Balbi B, Daniele SM, Rossi MF, Monje AL, Basiglio CL, Pelusa HF, Arriaga SMM
Source: Lupus 2020 Feb 16;:961203320904784
Publication date: 2020-02-16
Treatment of IgA nephropathy in children: a land without KDIGO guidance.
Author(s): Coppo R
Source: Pediatr Nephrol 2020 Feb 14;
Publication date: 2020-02-14
Crescentic glomerulonephritis in children.
Author(s): Mayer U, Schmitz J, Bräsen JH, Pape L
Source: Pediatr Nephrol 2020 Feb 12;
Publication date: 2020-02-12
Morphofunctional Effects of C5 Convertase Blockade in Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Report of Two Cases with Evidence of Terminal Complement Activation.
Author(s): Carrara C, Podestà MA, Abbate M, Rizzo P, Piras R, Alberti M, Daina E, Ruggenenti P, Remuzzi G
Source: Nephron 2020 Feb 12;:1-9
Publication date: 2020-02-12
Angiotensin II receptor agonist antibodies are associated with microvascular damage in lupus nephritis.
Author(s): Mejia-Vilet JM, López-Hernández YJ, Santander-Vélez JI, Trujeque-Matos M, Cruz C, Carranza de la Torre CA, Espinosa-Cruz V, Espinosa-González R, Uribe-Uribe NO, Morales-Buenrostro LE
Source: Lupus 2020 Feb 10;:961203320904787
Publication date: 2020-02-10
Wire-loop lesion is associated with serological immune abnormality, but not renal prognosis, in lupus nephritis.
Author(s): Zoshima T, Hara S, Mizushima I, Nishioka R, Ito K, Fujii H, Yamada K, Nomura H, Kawano M
Source: Lupus 2020 Feb 10;:961203320905652
Publication date: 2020-02-10
New therapeutic perspectives for IgA nephropathy in children.
Author(s): Cambier A, Gleeson PJ, Flament H, Le Stang MB, Monteiro RC
Source: Pediatr Nephrol 2020 Feb 10;
Publication date: 2020-02-10
IgA Nephropathy After Renal Transplant: Recurrences and De Novo Cases.
Author(s): Cazorla-López JM, Wu J, Villanego-Fernández F, Naranjo-Muñoz J, Vigara-Sánchez LA, García-García-Doncel A, Orellana-Chávez C, Moreno-Salazar A, García-Álvarez T, Mazuecos-Blanca A
Source: Transplant Proc 2020 Feb 6;
Publication date: 2020-02-6
Anti-Factor B Antibodies and Acute Postinfectious GN in Children.
Author(s): Chauvet S, Berthaud R, Devriese M, Mignotet M, Vieira Martins P, Robe-Rybkine T, Miteva MA, Gyulkhandanyan A, Ryckewaert A, Louillet F, Merieau E, Mestrallet G, Rousset-Rouvière C, Thervet E, Hogan J, Ulinski T, Villoutreix BO, Roumenina L, Boyer O, Frémeaux-Bacchi V
Source: J Am Soc Nephrol 2020 Feb 7;
Publication date: 2020-02-7
Screening for Cancer in Patients with Glomerular Diseases.
Author(s): Plaisier E, Ronco P
Source: Clin J Am Soc Nephrol 2020 Feb 4;
Publication date: 2020-02-4
Differential analysis of urinary albumin for membranous nephropathy patients by online capillary isoelectric focusing - Mass spectrometry.
Author(s): Tie C, Liu L, Feng T, Sa R, Xia Q, Liang H, Mao Y
Source: J Proteomics 2020 Jan 30;216:103676
Publication date: 2020-01-30
Reversal of endothelial dysfunction post-immunosuppressive therapy in adult-onset podocytopathy and primary membranous nephropathy.
Author(s): Inamdar N, Tomer S, Kalmath S, Bansal A, Yadav AK, Sharma V, Bahuguna P, Gorsi U, Arora S, Lal A, Kumar V, Rathi M, Kohli HS, Gupta KL, Ramachandran R
Source: Atherosclerosis 2020 Feb;295:38-44
Publication date: 2020-02
Genetic polymorphism in C3 is associated with progression in chronic kidney disease (CKD) patients with IgA nephropathy but not in other causes of CKD.
Author(s): Ibrahim ST, Chinnadurai R, Ali I, Payne D, Rice GI, Newman WG, Algohary E, Adam AG, Kalra PA
Source: PLoS One 2020;15(1):e0228101
Publication date: 2020
Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient).
Author(s): Binda V, Trezzi B, Del Papa N, Beretta L, Frontini G, Porata G, Fabbrini P, Pozzi MR, Messa P, Sinico RA, Moroni G
Source: J Nephrol 2020 Jan 30;
Publication date: 2020-01-30
Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab.
Author(s): Boyer-Suavet S, Andreani M, Lateb M, Savenkoff B, Brglez V, Benzaken S, Bernard G, Nachman PH, Esnault V, Seitz-Polski B
Source: Front Immunol 2019;10:3069
Publication date: 2019
Transplant outcomes in kidney recipients with lupus nephritis, and systematic review.
Author(s): Kim JE, Kim YC, Min SL, Lee H, Ha J, Chin HJ, Kim YS, Han SS
Source: Lupus 2020 Jan 29;:961203320902524
Publication date: 2020-01-29
Crescentic IgA nephropathy in children.
Author(s): Shima Y, Nakanishi K, Hama T, Mukaiyama H, Sato M, Tanaka Y, Tanaka R, Kaito H, Nozu K, Sako M, Iijima K, Yoshikawa N
Source: Pediatr Nephrol 2020 Jan 28;
Publication date: 2020-01-28
Low-dose ofatumumab for multidrug-resistant nephrotic syndrome in children: a randomized placebo-controlled trial.
Author(s): Ravani P, Pisani I, Bodria M, Caridi G, Degl'Innocenti ML, Ghiggeri GM
Source: Pediatr Nephrol 2020 Jan 28;
Publication date: 2020-01-28
Podocyte autophagy is associated with foot process effacement and proteinuria in patients with minimal change nephrotic syndrome.
Author(s): Ogawa-Akiyama A, Sugiyama H, Kitagawa M, Tanaka K, Kano Y, Mise K, Otaka N, Tanabe K, Morinaga H, Kinomura M, Uchida HA, Wada J
Source: PLoS One 2020;15(1):e0228337
Publication date: 2020
Long-term blood pressure behavior and progression to end-stage renal disease in patients with immunoglobulin A nephropathy: a single-center observational study in Italy.
Author(s): Russo E, Verzola D, Salvidio G, Bonino B, Picciotto D, Drovandi S, Pozzi C, Ferrario F, Pontremoli R, Garibotto G, Viazzi F
Source: J Hypertens 2020 Jan 20;
Publication date: 2020-01-20
Membranous Nephropathy Due to Anti-GBM Antibodies of Mice and Men.
Author(s): Glassock RJ
Source: Am J Nephrol 2020;51(2):96-98
Publication date: 2020
Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy.
Author(s): Guo Y, Wu X, Liu L, Zhang H, Yang L, Chen W
Source: Ren Fail 2020 Nov;42(1):122-130
Publication date: 2020-11
Glucose metabolism disorders in children with refractory nephrotic syndrome.
Author(s): Takahashi T, Okamoto T, Sato Y, Hayashi A, Ueda Y, Ariga T
Source: Pediatr Nephrol 2020 Jan 16;
Publication date: 2020-01-16
Increased frequency of PD-1hiCXCR5- T cells and B cells in patients with newly diagnosed IgA nephropathy.
Author(s): Wang X, Li T, Si R, Chen J, Qu Z, Jiang Y
Source: Sci Rep 2020 Jan 16;10(1):492
Publication date: 2020-01-16
Association of glomerular DNA damage and DNA methylation with one-year eGFR decline in IgA nephropathy.
Author(s): Hayashi K, Hishikawa A, Hashiguchi A, Azegami T, Yoshimoto N, Nakamichi R, Tokuyama H, Itoh H
Source: Sci Rep 2020 Jan 14;10(1):237
Publication date: 2020-01-14
Clinical relevance of membrane attack complex deposition in children with IgA nephropathy and Henoch-Schönlein purpura.
Author(s): Dumont C, Mérouani A, Ducruet T, Benoit G, Clermont MJ, Lapeyraque AL, Phan V, Patey N
Source: Pediatr Nephrol 2020 Jan 13;
Publication date: 2020-01-13
Long-term predictive value of acute kidney injury classification in diffuse proliferative lupus nephritis with acute kidney injury.
Author(s): Chen T, Zhou Y, Zhang J, Chen C, Pan J
Source: BMC Nephrol 2020 Jan 13;21(1):13
Publication date: 2020-01-13
Predicting and Defining Steroid Resistance in Pediatric Nephrotic Syndrome Using Plasma Proteomics.
Author(s): Agrawal S, Merchant ML, Kino J, Li M, Wilkey DW, Gaweda AE, Brier ME, Chanley MA, Gooding JR, Sumner SJ, Klein JB, Smoyer WE
Source: Kidney Int Rep 2020 Jan;5(1):66-80
Publication date: 2020-01
An Open-Label Pilot Study of Adrenocorticotrophic Hormone in the Treatment of IgA Nephropathy at High Risk of Progression.
Author(s): Zand L, Canetta P, Lafayette R, Aslam N, Jan N, Sethi S, Fervenza FC
Source: Kidney Int Rep 2020 Jan;5(1):58-65
Publication date: 2020-01
Lupus Nephritis Class IV-Global Is Associated with a Higher Risk of End-Stage Renal Disease than Class IV-Segmental.
Author(s): Oliveira C, Mariz H, Fernandes G, Costa D, Cavalcante MA, Valente L
Source: Nephron 2020 Jan 7;:1-8
Publication date: 2020-01-7
Clinicopathological factors for tubulointerstitial injury in lupus nephritis.
Author(s): Lan-Ting H, You-Ming C, Li-Xin W, Chen W, Xiao-Yan Z, Hong-Yan H
Source: Clin Rheumatol 2020 Jan 4;
Publication date: 2020-01-4
Antigens, antibodies, and membranous nephropathy: a decade of progress.
Author(s): Ahmad SB, Appel GB
Source: Kidney Int 2020 Jan;97(1):29-31
Publication date: 2020-01
Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study.
Author(s): Xie Z, Dong W, Li Z, Chen Y, Song L, Li R, Wu Y, Fu L, Liang H, Tao Y, Xie J, Wang W, Liu S, Ye Z, Shi W, Liang X
Source: Nephrology (Carlton) 2020 Mar;25(3):219-229
Publication date: 2020-03
Predictive value of mesangial C3 and C4d deposition in IgA nephropathy.
Author(s): Nam KH, Joo YS, Lee C, Lee S, Kim J, Yun HR, Park JT, Chang TI, Ryu DR, Yoo TH, Chin HJ, Kang SW, Jeong HJ, Lim BJ, Han SH
Source: Clin Immunol 2020 Feb;211:108331
Publication date: 2020-02
Effectiveness and safety of common therapeutic drugs for refractory lupus nephritis: A network meta-analysis.
Author(s): Zhou J, Tao MJ, Jin LR, Sheng J, Li Z, Peng H, Xu L, Yuan H
Source: Exp Ther Med 2020 Jan;19(1):665-671
Publication date: 2020-01
Glomerular disease in children: when to biopsy.
Author(s): McEwen ST, Rheault MN
Source: Nephrol Dial Transplant 2020 Jan 17;
Publication date: 2020-01-17
Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with De Novo Minimal Change Disease: A Multicenter, Randomized, Controlled Trial.
Author(s): Medjeral-Thomas NR, Lawrence C, Condon M, Sood B, Warwicker P, Brown H, Pattison J, Bhandari S, Barratt J, Turner N, Cook HT, Levy JB, Lightstone L, Pusey C, Galliford J, Cairns TD, Griffith M
Source: Clin J Am Soc Nephrol 2020 Jan 17;
Publication date: 2020-01-17
Therapeutic Myeloperoxidase Inhibition Attenuates Neutrophil Activation, ANCA-Mediated Endothelial Damage, and Crescentic GN.
Author(s): Antonelou M, Michaëlsson E, Evans RDR, Wang CJ, Henderson SR, Walker LSK, Unwin RJ, Salama AD
Source: J Am Soc Nephrol 2019 Dec 26;
Publication date: 2019-12-26
Large-Scale Whole-Genome Sequencing Reveals the Genetic Architecture of Primary Membranoproliferative GN and C3 Glomerulopathy.
Author(s): Levine AP, Chan MMY, Sadeghi-Alavijeh O, Wong EKS, Cook HT, Ashford S, Carss K, Christian MT, Hall M, Harris CL, McAlinden P, Marchbank KJ, Marks SD, Maxwell H, Megy K, Penkett CJ, Mozere M, Stirrups KE, Tuna S, Wessels J, Whitehorn D, Johnson SA, Gale DP
Source: J Am Soc Nephrol 2020 Jan 9;
Publication date: 2020-01-9
Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: protocol of a pilot randomised controlled trial.
Author(s): Scolari F, Dallera N, Gesualdo L, Santoro D, Pani A, Santostefano M, Feriozzi S, Mani LY, Boscutti G, Messa P, Magistroni R, Quaglia M, Ponticelli C, Ravani P
Source: BMJ Open 2019 Dec 4;9(12):e029232
Publication date: 2019-12-4
IgA1 deposition may induce NLRP3 expression and macrophage transdifferentiation of podocyte in IgA nephropathy.
Author(s): Peng W, Pei GQ, Tang Y, Tan L, Qin W
Source: J Transl Med 2019 Dec 3;17(1):406
Publication date: 2019-12-3
Graft failure of IgA nephropathy in renal allografts following living donor transplantation: predictive factor analysis of 102 biopsies.
Author(s): Zhang J, Chen GD, Qiu J, Liu GC, Chen LZ, Fu K, Wu ZX
Source: BMC Nephrol 2019 Dec 3;20(1):446
Publication date: 2019-12-3
Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy.
Author(s): Zou H, Li Y, Xu G
Source: BMC Nephrol 2019 Dec 2;20(1):442
Publication date: 2019-12-2
Relationship between renal tissues phospholipase A2 receptor and its serum antibody and clinical condition and prognosis of idiopathic membranous nephropathy: a meta-analysis.
Author(s): Dong D, Fan TT, Wang YY, Zhang L, Song L, Zhang L
Source: BMC Nephrol 2019 Dec 2;20(1):444
Publication date: 2019-12-2
Clinical impact of repeat renal biopsies in patients with lupus nephritis: Renal biopsy is essential especially later in the course of the disease.
Author(s): Marinaki S, Kapsia E, Liapis G, Gakiopoulou H, Skalioti C, Kolovou K, Boletis J
Source: Eur J Rheumatol 2019 Nov 25;:1-7
Publication date: 2019-11-25
Compositional alterations of gut microbiota in children with primary nephrotic syndrome after initial therapy.
Author(s): Kang Y, Feng D, Law HK, Qu W, Wu Y, Zhu GH, Huang WY
Source: BMC Nephrol 2019 Nov 26;20(1):434
Publication date: 2019-11-26
Long-term outcomes of patients with end-stage kidney disease due to membranoproliferative glomerulonephritis: an ANZDATA registry study.
Author(s): Wilson GJ, Cho Y, Teixiera-Pinto A, Isbel N, Campbell S, Hawley C, Johnson DW
Source: BMC Nephrol 2019 Nov 21;20(1):417
Publication date: 2019-11-21
The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice.
Author(s): Shi Y, Yao W, Sun L, Li G, Liu H, Ding P, Hu W, Xu H
Source: BMC Nephrol 2019 Nov 21;20(1):424
Publication date: 2019-11-21
Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Author(s): Liu ID, Willis NS, Craig JC, Hodson EM
Source: Cochrane Database Syst Rev 2019 Nov 21;2019(11)
Publication date: 2019-11-21
TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy.
Author(s): Makita Y, Suzuki H, Kano T, Takahata A, Julian BA, Novak J, Suzuki Y
Source: Kidney Int 2019 Sep 5;
Publication date: 2019-09-5
Risk factors and clinical characteristics of tacrolimus-induced acute nephrotoxicity in children with nephrotic syndrome: a retrospective case-control study.
Author(s): Gao P, Guan XL, Huang R, Shang-Guan XF, Luan JW, Liu MC, Xu H, Wang XW
Source: Eur J Clin Pharmacol 2019 Nov 19;
Publication date: 2019-11-19
A single APOL1 nephropathy variant increases risk of advanced lupus nephritis in Brazilians.
Author(s): Vajgel G, Lima SC, Santana DJS, Oliveira CBL, Costa DMN, Hicks PJ, Cavalcante MAGM, Langefeld CD, Valente LM, Crovella S, Kirsztajn GM, Freedman BI, Sandrin-Garcia P
Source: J Rheumatol 2019 Nov 15;
Publication date: 2019-11-15
Characterization of glomerular extracellular matrix in IgA nephropathy by proteomic analysis of laser-captured microdissected glomeruli.
Author(s): Paunas FTI, Finne K, Leh S, Osman TA, Marti HP, Berven F, Vikse BE
Source: BMC Nephrol 2019 Nov 14;20(1):410
Publication date: 2019-11-14
Complement dysregulation in glomerulonephritis.
Author(s): Kaartinen K, Safa A, Kotha S, Ratti G, Meri S
Source: Semin Immunol 2019 Oct;45:101331
Publication date: 2019-10
C4 nephritic factor in patients with immune-complex-mediated membranoproliferative glomerulonephritis and C3-glomerulopathy.
Author(s): Garam N, Prohászka Z, Szilágyi Á, Aigner C, Schmidt A, Gaggl M, Sunder-Plassmann G, Bajcsi D, Brunner J, Dumfarth A, Cejka D, Flaschberger S, Flögelova H, Haris Á, Hartmann Á, Heilos A, Mueller T, Rusai K, Arbeiter K, Hofer J, Jakab D, Sinkó M, Szigeti E, Bereczki C, Janko V, Kelen K, Reusz GS, Szabó AJ, Klenk N, Kóbor K, Kojc N, Knechtelsdorfer M, Laganovic M, Lungu AC, Meglic A, Rus R, Kersnik-Levart T, Macioniene E, Miglinas M, Pawłowska A, Stompór T, Podracka L, Rudnicki M, Mayer G, Romana Rysava, Reiterova J, Saraga M, Tomáš Seeman, Zieg J, Sládková E, Szabó T, Capitanescu A, Stancu S, Tisljar M, Galesic K, Tislér A, Vainumäe I, Windpessl M, Zaoral T, Zlatanova G, Csuka D
Source: Orphanet J Rare Dis 2019 Nov 8;14(1):247
Publication date: 2019-11-8
Individualizing Therapy in Lupus Nephritis.
Author(s): An Y, Zhang H, Liu Z
Source: Kidney Int Rep 2019 Oct;4(10):1366-1372
Publication date: 2019-10
IgA nephropathy is associated with elevated urinary mitochondrial DNA copy numbers.
Author(s): Yu BC, Cho NJ, Park S, Kim H, Choi SJ, Kim JK, Hwang SD, Gil HW, Lee EY, Jeon JS, Noh H, Han DC, Kim YH, Jin SY, Park MY, Kwon SH
Source: Sci Rep 2019 Nov 5;9(1):16068
Publication date: 2019-11-5
Long-Term Clinical Outcomes of Lupus Nephritis Patients Undergoing Peritoneal Dialysis: A Matched, Case-Control Study.
Author(s): Ye H, Cao P, Lin J, Yang X, Guo Q, Mao H, Yu X, Chen W
Source: Perit Dial Int 2019 Nov-Dec;39(6):570-573
Publication date: 2019-12
The Search for Biomarkers to Aid in Diagnosis, Differentiation, and Prognosis of Childhood Idiopathic Nephrotic Syndrome.
Author(s): Stone H, Magella B, Bennett MR
Source: Front Pediatr 2019;7:404
Publication date: 2019
Transplantation of Mouse Induced Pluripotent Stem Cell-Derived Podocytes in a Mouse Model of Membranous Nephropathy Attenuates Proteinuria.
Author(s): Ahmadi A, Moghadasali R, Ezzatizadeh V, Taghizadeh Z, Nassiri SM, Asghari-Vostikolaee MH, Alikhani M, Hadi F, Rahbarghazi R, Yazdi RS, Baharvand H, Aghdami N
Source: Sci Rep 2019 Oct 29;9(1):15467
Publication date: 2019-10-29
New-Onset Diabetes Mellitus in Patients with Idiopathic Membranous Nephropathy Undergoing Tacrolimus and Low-Dose Corticosteroid Therapy.
Author(s): Shao L, Jin J, Ye B, Xu B, Li Y, Gong J, Zhang J, Chen M, He Q
Source: Kidney Blood Press Res 2019 Oct 23;:1-11
Publication date: 2019-10-23
Pathologic tonsillar findings similar to IgA nephropathy and the role of tonsillectomy in a patient with nephrotic syndrome.
Author(s): Enya T, Miyazawa T, Miyazaki K, Oshima R, Morimoto Y, Okada M, Takemura T, Sugimoto K
Source: BMC Nephrol 2019 Oct 22;20(1):381
Publication date: 2019-10-22
Immune cell infiltration characteristics and related core genes in lupus nephritis: results from bioinformatic analysis.
Author(s): Cao Y, Tang W, Tang W
Source: BMC Immunol 2019 Oct 21;20(1):37
Publication date: 2019-10-21
Neutrophil extracellular traps are a source of extracellular HMGB1 in lupus nephritis: associations with clinical and histopathological features.
Author(s): Whittall-García LP, Torres-Ruiz J, Zentella-Dehesa A, Tapia-Rodríguez M, Alcocer-Varela J, Mendez-Huerta N, Gómez-Martín D
Source: Lupus 2019 Nov;28(13):1549-1557
Publication date: 2019-11
More about Factor H Autoantibodies in Membranous Nephropathy.
Author(s): Valoti E, Noris M, Remuzzi G
Source: N Engl J Med 2019 Oct 17;381(16):1590-1592
Publication date: 2019-10-17
Post-transplant recurrence of steroid resistant nephrotic syndrome in children: the Italian experience.
Author(s): Morello W, Puvinathan S, Puccio G, Ghiggeri GM, Dello Strologo L, Peruzzi L, Murer L, Cioni M, Guzzo I, Cocchi E, Benetti E, Testa S, Ghio L, Caridi G, Cardillo M, Torelli R, Montini G
Source: J Nephrol 2019 Oct 15;
Publication date: 2019-10-15
Complement Inhibitors in Clinical Trials for Glomerular Diseases.
Author(s): Zipfel PF, Wiech T, Rudnick R, Afonso S, Person F, Skerka C
Source: Front Immunol 2019;10:2166
Publication date: 2019
Associations of ABO blood type and galactose-deficient immunoglobulin A1 with adverse outcomes in patients with IgA nephropathy.
Author(s): Wang M, Lv J, Chen P, Yu G, Shi S, Liu L, Zhou X, Xu D, Zhao M, Zhang H
Source: Nephrol Dial Transplant 2019 Oct 11;
Publication date: 2019-10-11
Antiphospholipid antibodies in patients with lupus nephritis: clinical correlations and associations with long-term outcomes.
Author(s): Yap DYH, Thong KM, Yung S, Tang C, Ma BMY, Chan TM
Source: Lupus 2019 Oct;28(12):1460-1467
Publication date: 2019-10
Biomarkers to Predict Progression in IgA Nephropathy.
Author(s): Cheung CK, Barratt J
Source: Clin J Am Soc Nephrol 2019 Oct 7;14(10):1421-1423
Publication date: 2019-10-7
Phenotypic variability in two patients with tumor necrosis factor receptor associated periodic fever syndrome emphasizes a rare manifestation: Immunoglobulin A nephropathy.
Author(s): Balci S, Kisla Ekinci RM, Melek E, Atmis B, Bisgin A, Yilmaz M
Source: Eur J Med Genet 2019 Oct 3;:103780
Publication date: 2019-10-3
Impact of stringent response in proteinuria on long-term renal outcomes in proliferative lupus nephritis.
Author(s): Won J, Lee JS, Oh JS, Kim YG, Lee CK, Yoo B, Hong S
Source: Lupus 2019 Oct;28(11):1294-1301
Publication date: 2019-10
Treatment of idiopathic membranous nephropathy in adults: KDIGO 2012, cyclophosphamide and cyclosporine A are out, rituximab is the new normal.
Author(s): Rojas-Rivera JE, Carriazo S, Ortiz A
Source: Clin Kidney J 2019 Oct;12(5):629-638
Publication date: 2019-10
Has The Time Arrived to Refine The Indications of Immunosuppressive Therapy and Prognosis in IgA Nephropathy?
Author(s): Obrișcă B, Sinescu I, Ismail G, Mircescu G
Source: J Clin Med 2019 Oct 2;8(10)
Publication date: 2019-10-2
Risk factors associated with IgA vasculitis with nephritis (Henoch-Schönlein purpura nephritis) progressing to unfavorable outcomes: A meta-analysis.
Author(s): Shi D, Chan H, Yang X, Zhang G, Yang H, Wang M, Li Q
Source: PLoS One 2019;14(10):e0223218
Publication date: 2019
Membranous Nephropathy Posttransplantation: An Update of the Pathophysiology and Management.
Author(s): Leon J, Pérez-Sáez MJ, Batal I, Beck LH Jr, Rennke HG, Canaud G, Legendre C, Pascual J, Riella LV
Source: Transplantation 2019 Oct;103(10):1990-2002
Publication date: 2019-10
T cell-specific STAT3 deficiency abrogates lupus nephritis.
Author(s): Yoshida N, He F, Kyttaris VC
Source: Lupus 2019 Oct;28(12):1468-1472
Publication date: 2019-10
Rethinking Lupus Nephritis Classification on a Molecular Level.
Author(s): Almaani S, Prokopec SD, Zhang J, Yu L, Avila-Casado C, Wither J, Scholey JW, Alberton V, Malvar A, Parikh SV, Boutros PC, Rovin BH, Reich HN
Source: J Clin Med 2019 Sep 23;8(10)
Publication date: 2019-09-23
Possible beneficial association between renin-angiotensin-aldosterone-system blockade usage and graft prognosis in allograft IgA nephropathy: a retrospective cohort study.
Author(s): Park S, Baek CH, Go H, Kim YH, Min SI, Ha J, Kim YC, Lee JP, Kim YS, Moon KC, Park SK, Lee H
Source: BMC Nephrol 2019 Sep 11;20(1):354
Publication date: 2019-09-11
Transcriptomic and Epigenetic Alterations in Dendritic Cells Correspond With Chronic Kidney Disease in Lupus Nephritis.
Author(s): Wardowska A, Komorniczak M, Bułło-Piontecka B, Dȩbska-Ślizień MA, Pikuła M
Source: Front Immunol 2019;10:2026
Publication date: 2019
Umbilical arterial Doppler ultrasonography predicts late pregnancy outcomes in patients with lupus nephritis: a multicenter study from southern China.
Author(s): Chen D, Yuan S, Lao M, Zhan Y, Xu H, Liang L, Cai X, Wang X, Zhan Z
Source: Lupus 2019 Oct;28(11):1312-1319
Publication date: 2019-10
Urinary tract infection in children with nephrotic syndrome: A systematic review and meta-analysis.
Author(s): Sorkhi H, Riahi SM, Ebrahimpour S, Shaikh N, Rostami A
Source: Microb Pathog 2019 Dec;137:103718
Publication date: 2019-12
Does the renal expression of Toll-like receptors play a role in patients with IgA nephropathy?
Author(s): Ciferska H, Honsova E, Lodererova A, Hruskova Z, Neprasova M, Vachek J, Suchanek M, Zima T, Coppo R, Tesar V, Novak J, Maixnerova D
Source: J Nephrol 2019 Sep 5;
Publication date: 2019-09-5
Membranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R era.
Author(s): Safar-Boueri L, Piya A, Beck LH Jr, Ayalon R
Source: Pediatr Nephrol 2019 Dec 6;
Publication date: 2019-12-6
Rituximab in minimal change disease and focal segmental glomerulosclerosis.
Author(s): Kronbichler A, Gauckler P, Bruchfeld A
Source: Nephrol Dial Transplant 2019 Oct 3;
Publication date: 2019-10-3
Paediatric immune-mediated renal disease: an overview.
Author(s): Oni L
Source: Nephrol Dial Transplant 2019 Oct 5;
Publication date: 2019-10-5
Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
Author(s): Yang X, Ou J, Zhang H, Xu X, Zhu L, Li Q, Li J, Xie D, Sun J, Zha Y, Li Y, Tian J, Liu Y, Hou FF
Source: Am J Kidney Dis 2019 Oct 9;
Publication date: 2019-10-9
Histological prognostic factors in children with Henoch-Schönlein purpura nephritis.
Author(s): Delbet JD, Geslain G, Auger M, Hogan J, Salomon R, Peuchmaur M, Deschênes G, Buob D, Parmentier C, Ulinski T
Source: Pediatr Nephrol 2019 Nov 6;
Publication date: 2019-11-6
Immunoglobulin serum levels in rituximab-treated patients with steroid-dependent nephrotic syndrome.
Author(s): Parmentier C, Delbet JD, Decramer S, Boyer O, Hogan J, Ulinski T
Source: Pediatr Nephrol 2019 Nov 8;
Publication date: 2019-11-8
Additive Therapeutic Effects of Mesenchymal Stem Cells and IL-37 for Systemic Lupus Erythematosus.
Author(s): Xu J, Chen J, Li W, Lian W, Huang J, Lai B, Li L, Huang Z
Source: J Am Soc Nephrol 2019 Oct 11;
Publication date: 2019-10-11
Molecular stratification of idiopathic nephrotic syndrome.
Author(s): Saleem MA
Source: Nat Rev Nephrol 2019 Dec;15(12):750-765
Publication date: 2019-12
Lower prednisone dosing for steroid-sensitive nephrotic syndrome relapse: a prospective randomized pilot study.
Author(s): Borovitz Y, Alfandary H, Haskin O, Levi S, Kaz S, Davidovits M, Dagan A
Source: Eur J Pediatr 2019 Nov 14;
Publication date: 2019-11-14
The implications of focal segmental glomerulosclerosis in children with IgA nephropathy.
Author(s): Trimarchi H, Coppo R
Source: Pediatr Nephrol 2019 Nov 26;
Publication date: 2019-11-26
Kinin B1 Receptor Is Important in the Pathogenesis of Myeloperoxidase-Specific ANCA GN.
Author(s): Hu P, Su H, Xiao H, Gou SJ, Herrera CA, Alba MA, Kakoki M, Falk RJ, Jennette JC
Source: J Am Soc Nephrol 2019 Nov 26;
Publication date: 2019-11-26
A Modified Peptide Derived from Goodpasture Autoantigen Arrested and Attenuated Kidney Injuries in a Rat Model of Anti-GBM Glomerulonephritis.
Author(s): Shi Y, Jia XY, Gu QH, Wang M, Cui Z, Zhao MH
Source: J Am Soc Nephrol 2019 Oct 30;
Publication date: 2019-10-30
Glomerular endothelial activation, C4d deposits and microangiopathy in immunoglobulin A nephropathy.
Author(s): Trimarchi H, Coppo R
Source: Nephrol Dial Transplant 2019 Nov 22;
Publication date: 2019-11-22
Management of Membranous Nephropathy after MENTOR.
Author(s): Trivin-Avillach C, Beck LH Jr
Source: Clin J Am Soc Nephrol 2019 Nov 18;
Publication date: 2019-11-18
Using Electronic Health Record Data to Rapidly Identify Children with Glomerular Disease for Clinical Research.
Author(s): Denburg MR, Razzaghi H, Bailey LC, Soranno DE, Pollack AH, Dharnidharka VR, Mitsnefes MM, Smoyer WE, Somers MJG, Zaritsky JJ, Flynn JT, Claes DJ, Dixon BP, Benton M, Mariani LH, Forrest CB, Furth SL
Source: J Am Soc Nephrol 2019 Nov 15;
Publication date: 2019-11-15
TBC1D8B Mutations Implicate RAB11-Dependent Vesicular Trafficking in the Pathogenesis of Nephrotic Syndrome.
Author(s): Kampf LL, Schneider R, Gerstner L, Thünauer R, Chen M, Helmstädter M, Amar A, Onuchic-Whitford AC, Loza Munarriz R, Berdeli A, Müller D, Schrezenmeier E, Budde K, Mane S, Laricchia KM, Rehm HL, MacArthur DG, Lifton RP, Walz G, Römer W, Bergmann C, Hildebrandt F, Hermle T
Source: J Am Soc Nephrol 2019 Nov 15;
Publication date: 2019-11-15
Altered B-Lymphocyte Homeostasis in Idiopathic Nephrotic Syndrome.
Author(s): Ling C, Wang X, Chen Z, Fan J, Meng Q, Zhou N, Sun Q, Hua L, Gui J, Liu X
Source: Front Pediatr 2019;7:377
Publication date: 2019
Ofatumumab rescue treatment in post-transplant recurrence of focal segmental glomerulosclerosis.
Author(s): Colucci M, Labbadia R, Vivarelli M, Camassei FD, Emma F, Dello Strologo L
Source: Pediatr Nephrol 2019 Oct 30;
Publication date: 2019-10-30
Clinicopathological features of C3 glomerulopathy in children: a single-center experience.
Author(s): Drake KA, Ellington N, Gattineni J, Torrealba JR, Hendricks AR
Source: Pediatr Nephrol 2019 Oct 30;
Publication date: 2019-10-30
C3 glomerulopathy.
Author(s): Koopman JJE, de Vries APJ, Bajema IM
Source: Nephrol Dial Transplant 2019 Oct 17;
Publication date: 2019-10-17
Sensitivity and Specificity of Pathologic Findings to Diagnose Lupus Nephritis.
Author(s): Kudose S, Santoriello D, Bomback AS, Stokes MB, D'Agati VD, Markowitz GS
Source: Clin J Am Soc Nephrol 2019 Oct 25;
Publication date: 2019-10-25
Prognosis and acute complications at the first onset of idiopathic nephrotic syndrome in children: a nationwide survey in Japan (JP-SHINE study).
Author(s): Sato M, Ishikura K, Ando T, Kikunaga K, Terano C, Hamada R, Ishimori S, Hamasaki Y, Araki Y, Gotoh Y, Nakanishi K, Nakazato H, Matsuyama T, Iijima K, Yoshikawa N, Ito S, Honda M
Source: Nephrol Dial Transplant 2019 Sep 24;
Publication date: 2019-09-24
Efficacy and safety of leflunomide in IgA nephropathy: a systematic review and meta-analysis.
Author(s): Yi J, He Z, Xu S, Feng S
Source: Int Urol Nephrol 2019 Sep 12;
Publication date: 2019-09-12
Infrequent tacrolimus-induced nephrotoxicity in French patients with steroid-dependent nephrotic syndrome.
Author(s): Delbet JD, Aoun B, Buob D, Degheili J, Brocheriou I, Ulinski T
Source: Pediatr Nephrol 2019 Sep 13;
Publication date: 2019-09-13
CD80 expression and infiltrating regulatory T cells in idiopathic nephrotic syndrome of childhood.
Author(s): Eroglu FK, Orhan D, İnözü M, Duzova A, Gulhan B, Ozaltin F, Topaloglu R
Source: Pediatr Int 2019 Sep 12;
Publication date: 2019-09-12
Comparative efficacy of 13 immunosuppressive agents for idiopathic membranous nephropathy in adults with nephrotic syndrome: a systematic review and network meta-analysis.
Author(s): Zheng Q, Yang H, Liu W, Sun W, Zhao Q, Zhang X, Jin H, Sun L
Source: BMJ Open 2019 Sep 11;9(9):e030919
Publication date: 2019-09-11
Plasma Galactose-Deficient IgA1 and C3 and CKD Progression in IgA Nephropathy.
Author(s): Chen P, Yu G, Zhang X, Xie X, Wang J, Shi S, Liu L, Lv J, Zhang H
Source: Clin J Am Soc Nephrol 2019 Sep 11;
Publication date: 2019-09-11
Role of phospholipase A2 receptor 1 antibody level at diagnosis for long-term renal outcome in membranous nephropathy.
Author(s): Mahmud M, Pinnschmidt HO, Reinhard L, Harendza S, Wiech T, Stahl RAK, Hoxha E
Source: PLoS One 2019;14(9):e0221293
Publication date: 2019
Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis: a randomised controlled trial.
Author(s): Nikolopoulou A, Condon M, Turner-Stokes T, Cook HT, Duncan N, Galliford JW, Levy JB, Lightstone L, Pusey CD, Roufosse C, Cairns TD, Griffith ME
Source: BMC Nephrol 2019 Sep 6;20(1):352
Publication date: 2019-09-6
A clinicopathological comparison between IgA nephropathy and Henoch-Schönlein purpura nephritis in children: use of the Oxford classification.
Author(s): Li X, Tang M, Yao X, Zhang N, Fan J, Zhou N, Sun Q, Chen Z, Meng Q, Lei L, Zhang H, Ling C, Hua L, Chen X, Liu X
Source: Clin Exp Nephrol 2019 Aug 29;
Publication date: 2019-08-29
Analysis of 14 Patients With Congenital Nephrotic Syndrome.
Author(s): Chen Y, Zhang Y, Wang F, Zhang H, Zhong X, Xiao H, Yao Y, Jiang Y, Ding J, Hou X
Source: Front Pediatr 2019;7:341
Publication date: 2019
Safety and Efficacy of Pneumococcal Vaccination in Pediatric Nephrotic Syndrome.
Author(s): Goonewardene ST, Tang C, Tan LT, Chan KG, Lingham P, Lee LH, Goh BH, Pusparajah P
Source: Front Pediatr 2019;7:339
Publication date: 2019
Efficacy and safety of immunosuppressive treatment in IgA nephropathy: a meta-analysis of randomized controlled trials.
Author(s): Zhang Z, Yang Y, Jiang SM, Li WG
Source: BMC Nephrol 2019 Aug 27;20(1):333
Publication date: 2019-08-27
Treatment of Membranous Nephropathy in Patients With THSD7A Antibodies Using Immunoadsorption.
Author(s): Weinmann-Menke J, Holtz S, Sollinger D, Dörken M, Boedecker S, Schamberger B, Pfister F, Amann K, Lutz J
Source: Am J Kidney Dis 2019 Aug 23;
Publication date: 2019-08-23
Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role.
Author(s): Liu W, Gao C, Dai H, Zheng Y, Dong Z, Gao Y, Liu F, Zhang Z, Liu Z, Liu W, Liu B, Liu Q, Shi J
Source: Front Immunol 2019;10:1809
Publication date: 2019
Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1.
Author(s): Rizk DV, Saha MK, Hall S, Novak L, Brown R, Huang ZQ, Fatima H, Julian BA, Novak J
Source: J Am Soc Nephrol 2019 Aug 23;
Publication date: 2019-08-23
An evaluation of phase angle, bioelectrical impedance vector analysis and impedance ratio for the assessment of disease status in children with nephrotic syndrome.
Author(s): Brantlov S, Jødal L, Andersen RF, Lange A, Rittig S, Ward LC
Source: BMC Nephrol 2019 Aug 22;20(1):331
Publication date: 2019-08-22
Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth.
Author(s): Topaloğlu R, Gülhan B, Çelegen K, İnözü M, Hayran M, Düzova A, Ozaltin F
Source: Front Pediatr 2019;7:313
Publication date: 2019
The Association of Glomerular Glucocorticoid Receptor Expression with Responsiveness to Corticosteroid Treatment in IgA Nephropathy.
Author(s): Kee YK, Nam BY, Jhee JH, Park JT, Lim BJ, Yoo TH, Kang SW, Jeong HJ, Han SH
Source: Am J Nephrol 2019;50(3):187-195
Publication date: 2019
"Associated" or "Secondary" IgA nephropathy? An outcome analysis.
Author(s): Obrișcă B, Ștefan G, Gherghiceanu M, Mandache E, Ismail G, Stancu S, Boitan B, Ion O, Mircescu G
Source: PLoS One 2019;14(8):e0221014
Publication date: 2019
Comparison of the effects of hydroxychloroquine and corticosteroid treatment on proteinuria in IgA nephropathy: a case-control study.
Author(s): Yang YZ, Chen P, Liu LJ, Cai QQ, Shi SF, Chen YQ, Lv JC, Zhang H
Source: BMC Nephrol 2019 Aug 5;20(1):297
Publication date: 2019-08-5
Prolonged Impairment of Immunological Memory After Anti-CD20 Treatment in Pediatric Idiopathic Nephrotic Syndrome.
Author(s): Colucci M, Carsetti R, Serafinelli J, Rocca S, Massella L, Gargiulo A, Lo Russo A, Capponi C, Cotugno N, Porzio O, Onetti Muda A, Palma P, Emma F, Vivarelli M
Source: Front Immunol 2019;10:1653
Publication date: 2019
Prevention of relapses with levamisole as adjuvant therapy in children with a first episode of idiopathic nephrotic syndrome: study protocol for a double blind, randomised placebo-controlled trial (the LEARNS study).
Author(s): Veltkamp F, Khan DH, Reefman C, Veissi S, van Oers HA, Levtchenko E, Mathôt RAA, Florquin S, van Wijk JAE, Schreuder MF, Haverman L, Bouts AHM
Source: BMJ Open 2019 Aug 1;9(8):e027011
Publication date: 2019-08-1
Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial).
Author(s): Nagano C, Sako M, Kamei K, Ishikura K, Nakamura H, Nakanishi K, Omori T, Nozu K, Iijima K
Source: BMC Nephrol 2019 Aug 2;20(1):293
Publication date: 2019-08-2
Immunostaining for galactose-deficient immunoglobulin A is not specific for primary immunoglobulin A nephropathy.
Author(s): Cassol CA, Bott C, Nadasdy GM, Alberton V, Malvar A, Nagaraja HN, Nadasdy T, Rovin BH, Satoskar AA
Source: Nephrol Dial Transplant 2019 Aug 1;
Publication date: 2019-08-1
Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.
Author(s): Webb NJA, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Deeks JJ, Wheatley K, Ives NJ
Source: BMJ 2019 May 23;365:l1800
Publication date: 2019-05-23
Association between native T1 mapping of the kidney and renal fibrosis in patients with IgA nephropathy.
Author(s): Graham-Brown MP, Singh A, Wormleighton J, Brunskill NJ, McCann GP, Barratt J, Burton JO, Xu G
Source: BMC Nephrol 2019 Jul 11;20(1):256
Publication date: 2019-07-11
Prevalence of Cardiovascular Disease Risk Factors in Childhood Glomerular Diseases.
Author(s): Ashoor IF, Mansfield SA, O'Shaughnessy MM, Parekh RS, Zee J, Vasylyeva TL, Kogon AJ, Sethna CB, Glenn DA, Chishti AS, Weaver DJ, Helmuth ME, Fernandez HE, Rheault MN
Source: J Am Heart Assoc 2019 Jul 16;8(14):e012143
Publication date: 2019-07-16
Immunoglobulin A Nephropathy. Recurrence After Renal Transplantation.
Author(s): Moroni G, Belingheri M, Frontini G, Tamborini F, Messa P
Source: Front Immunol 2019;10:1332
Publication date: 2019
Serum complement C4 is an important prognostic factor for IgA nephropathy: a retrospective study.
Author(s): Bi TD, Zheng JN, Zhang JX, Yang LS, Liu N, Yao L, Liu LL
Source: BMC Nephrol 2019 Jul 4;20(1):244
Publication date: 2019-07-4
Membranous Nephropathy (MN) Recurrence After Renal Transplantation.
Author(s): Passerini P, Malvica S, Tripodi F, Cerutti R, Messa P
Source: Front Immunol 2019;10:1326
Publication date: 2019
Discovery of endoplasmic reticulum calcium stabilizers to rescue ER-stressed podocytes in nephrotic syndrome.
Author(s): Park SJ, Kim Y, Yang SM, Henderson MJ, Yang W, Lindahl M, Urano F, Chen YM
Source: Proc Natl Acad Sci U S A 2019 Jul 9;116(28):14154-14163
Publication date: 2019-07-9
Levamisole in Children with Idiopathic Nephrotic Syndrome: Clinical Efficacy and Pathophysiological Aspects.
Author(s): Mühlig AK, Lee JY, Kemper MJ, Kronbichler A, Yang JW, Lee JM, Shin JI, Oh J
Source: J Clin Med 2019 Jun 16;8(6)
Publication date: 2019-06-16
Limited sampling strategy to predict mycophenolic acid area under the curve in pediatric patients with nephrotic syndrome: a retrospective cohort study.
Author(s): Sobiak J, Resztak M, Pawiński T, Żero P, Ostalska-Nowicka D, Zachwieja J, Chrzanowska M
Source: Eur J Clin Pharmacol 2019 Sep;75(9):1249-1259
Publication date: 2019-09
Antiphospholipid Antibodies in Patients with Membranous Nephropathy.
Author(s): Zhang Q, Wang Y, Xu Y, Lan L, Chen J, Han F
Source: Nephron 2019 Aug 27;:1-6
Publication date: 2019-08-27
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome.
Author(s): Cuzzoni E, Franca R, De Iudicibus S, Marcuzzi A, Lucafò M, Pelin M, Favretto D, Monti E, Morello W, Ghio L, La Scola C, Mencarelli F, Pasini A, Montini G, Decorti G, Stocco G
Source: Eur J Clin Pharmacol 2019 Aug 28;
Publication date: 2019-08-28
Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis.
Author(s): Satoskar AA, Parikh SV, Nadasdy T
Source: Nat Rev Nephrol 2019 Aug 9;
Publication date: 2019-08-9
Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine.
Author(s): Fujinaga S, Hirano D, Nishino T, Umeda C, Watanabe Y, Nakagawa M
Source: Pediatr Nephrol 2019 Aug 21;
Publication date: 2019-08-21
Risk of Nephrotic Syndrome for Non-Steroidal Anti-Inflammatory Drug Users.
Author(s): Bakhriansyah M, Souverein PC, van den Hoogen MWF, de Boer A, Klungel OH
Source: Clin J Am Soc Nephrol 2019 Aug 15;
Publication date: 2019-08-15
Membranous glomerulonephritis: a step forward in B-cell targeting therapy?
Author(s): Dahan K, Boffa JJ
Source: Nephrol Dial Transplant 2019 Aug 4;
Publication date: 2019-08-4
Relationship between complement deposition and the Oxford classification score and their combined effects on renal outcome in immunoglobulin A nephropathy.
Author(s): Park S, Kim HW, Park JT, Chang TI, Kang EW, Ryu DR, Yoo TH, Chin HJ, Jeong HJ, Kang SW, Lim BJ, Han SH
Source: Nephrol Dial Transplant 2019 Aug 3;
Publication date: 2019-08-3
Plasma galactose-deficient immunoglobulin A1 and loss of kidney function in patients with immunoglobulin A vasculitis nephritis.
Author(s): Zhang X, Xie X, Shi S, Liu L, Lv J, Zhang H
Source: Nephrol Dial Transplant 2019 Aug 3;
Publication date: 2019-08-3
Atypical IgM on T cells predict relapse and steroid dependence in idiopathic nephrotic syndrome.
Author(s): Colucci M, Carsetti R, Rosado MM, Cascioli S, Bruschi M, Candiano G, Corpetti G, Giardino L, Serafinelli J, Giannone C, Ghiggeri GM, Rastaldi MP, Sitia R, Emma F, Vivarelli M
Source: Kidney Int 2019 May 7;
Publication date: 2019-05-7
T-lymphocyte in ANCA-associated vasculitis: what do we know? A pathophysiological and therapeutic approach.
Author(s): Martinez Valenzuela L, Bordignon Draibe J, Fulladosa Oliveras X, Bestard Matamoros O, Cruzado Garrit JM, Torras Ambrós J
Source: Clin Kidney J 2019 Aug;12(4):503-511
Publication date: 2019-08
High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy.
Author(s): Seitz-Polski B, Dahan K, Debiec H, Rousseau A, Andreani M, Zaghrini C, Ticchioni M, Rosenthal A, Benzaken S, Bernard G, Lambeau G, Ronco P, Esnault VLM
Source: Clin J Am Soc Nephrol 2019 Jul 24;
Publication date: 2019-07-24
Hypertension in Childhood Nephrotic Syndrome.
Author(s): Shatat IF, Becton LJ, Woroniecki RP
Source: Front Pediatr 2019;7:287
Publication date: 2019
Accelerating the Depletion of Circulating Anti-Phospholipase A2 Receptor Antibodies in Patients with Severe Membranous Nephropathy: Preliminary Findings with Double Filtration Plasmapheresis and Ofatumumab.
Author(s): Podestà MA, Gennarini A, Portalupi V, Rota S, Alessio MG, Remuzzi G, Ruggenenti P
Source: Nephron 2019 Jul 23;:1-6
Publication date: 2019-07-23
Apoptotic Cell-Induced, Antigen-Specific Immunoregulation to Treat Experimental Antimyeloperoxidase GN.
Author(s): Gan PY, Godfrey AS, Ooi JD, O'Sullivan KM, Oudin V, Kitching AR, Holdsworth SR
Source: J Am Soc Nephrol 2019 Jul 23;
Publication date: 2019-07-23
IgA Nephropathy in Elderly Patients.
Author(s): Sevillano AM, Diaz M, Caravaca-Fontán F, Barrios C, Bernis C, Cabrera J, Calviño J, Castillo L, Cobelo C, Delgado-Mallén P, Espinosa M, Fernandez-Juarez G, Fernandez-Reyes MJ, Garcia-Osuna R, Garcia P, Goicoechea M, Gonzalez-Cabrera F, Guzmán DA, Heras M, Martín-Reyes G, Martinez A, Olea T, Peña JK, Quintana LF, Rabasco C, López Revuelta K, Rodas L, Rodriguez-Mendiola N, Rodriguez E, San Miguel L, Sanchez de la Nieta MD, Shabaka A, Sierra M, Valera A, Velo M, Verde E, Ballarin J, Noboa O, Moreno JA, Gutiérrez E, Praga M
Source: Clin J Am Soc Nephrol 2019 Jul 16;
Publication date: 2019-07-16
Differences in clinico-pathological characteristics and outcomes between proteinase 3-ANCA positivity and myeloperoxidase-ANCA positivity in lupus nephritis.
Author(s): Li C, Wang JJ, Zhou ML, Liang DD, Yang J, Zhu HX, Hu WX, Zhang HT
Source: Lupus 2019 Jul 10;:961203319861680
Publication date: 2019-07-10
Analysis of HLA-G expression in renal tissue in lupus nephritis: a pilot study.
Author(s): Foschi V, Bortolotti D, Doyle AF, Stratigou V, Stephens L, Trivedi P, Rinaldi R, Padovan M, Bortoluzzi A, Lightstone L, Cairns TD, Botto M, Cook TH, Rizzo R, Govoni M, Pickering MC
Source: Lupus 2019 Jul 10;:961203319860582
Publication date: 2019-07-10
Remission and long-term outcomes of proliferative lupus nephritis: retrospective study of 96 patients from Saudi Arabia.
Author(s): Almalki AH, Alrowaie FA, Alhozali HM, Almalki NK, Alsubei AI, Alturki MS, Sadagah LF
Source: Lupus 2019 Jul 11;:961203319860584
Publication date: 2019-07-11
Delayed lupus nephritis in the course of systemic lupus erythematosus is associated with a poorer treatment response: a multicentre, retrospective cohort study in Japan.
Author(s): Nakano M, Kubo K, Shirota Y, Iwasaki Y, Takahashi Y, Igari T, Inaba Y, Takeshima Y, Tateishi S, Yamashita H, Miyazaki M, Sato H, Kanda H, Kaneko H, Ishii T, Fujio K, Tanaka N, Mimori A
Source: Lupus 2019 Jul 11;:961203319860200
Publication date: 2019-07-11
Dyslipidemia and cardiovascular health in childhood nephrotic syndrome.
Author(s): Hari P, Khandelwal P, Smoyer WE
Source: Pediatr Nephrol 2019 Jul 13;
Publication date: 2019-07-13
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
Author(s): Fervenza FC, Appel GB, Barbour SJ, Rovin BH, Lafayette RA, Aslam N, Jefferson JA, Gipson PE, Rizk DV, Sedor JR, Simon JF, McCarthy ET, Brenchley P, Sethi S, Avila-Casado C, Beanlands H, Lieske JC, Philibert D, Li T, Thomas LF, Green DF, Juncos LA, Beara-Lasic L, Blumenthal SS, Sussman AN, Erickson SB, Hladunewich M, Canetta PA, Hebert LA, Leung N, Radhakrishnan J, Reich HN, Parikh SV, Gipson DS, Lee DK, da Costa BR, Jüni P, Cattran DC
Source: N Engl J Med 2019 Jul 4;381(1):36-46
Publication date: 2019-07-4
Diagnosing renal involvement in connective tissue disease: interpretation of anti-nuclear autoantibody tests.
Author(s): Nimmo A, Chopra C, Hunter RW
Source: Nephrol Dial Transplant 2019 Jul 11;
Publication date: 2019-07-11
Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy.
Author(s): Barrett C, Willcocks LC, Jones RB, Tarzi RM, Henderson RB, Cai G, Gisbert SI, Belson AS, Savage CO
Source: Nephrol Dial Transplant 2019 Jun 26;
Publication date: 2019-06-26
Genetic Identification of Two Novel Loci Associated with Steroid-Sensitive Nephrotic Syndrome.
Author(s): Dufek S, Cheshire C, Levine AP, Trompeter RS, Issler N, Stubbs M, Mozere M, Gupta S, Klootwijk E, Patel V, Hothi D, Waters A, Webb H, Tullus K, Jenkins L, Godinho L, Levtchenko E, Wetzels J, Knoers N, Teeninga N, Nauta J, Shalaby M, Eldesoky S, Kari JA, Thalgahagoda S, Ranawaka R, Abeyagunawardena A, Adeyemo A, Kristiansen M, Gbadegesin R, Webb NJ, Gale DP, Stanescu HC, Kleta R, Bockenhauer D
Source: J Am Soc Nephrol 2019 Jul 1;
Publication date: 2019-07-1
LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients.
Author(s): Shah L, Hooper DK, Okamura D, Wallace D, Moodalbail D, Gluck C, Koziell A, Zaritsky JJ
Source: Pediatr Nephrol 2019 Jun 27;
Publication date: 2019-06-27
Management of Adult Minimal Change Disease.
Author(s): Korbet SM, Whittier WL
Source: Clin J Am Soc Nephrol 2019 Jun 7;14(6):911-913
Publication date: 2019-06-7
Open-Label Clinical Trials of Oral Pulse Dexamethasone for Adults with Idiopathic Nephrotic Syndrome.
Author(s): Cho ME, Branton MH, Smith DA, Bartlett L, Howard L, Reynolds JC, Rosenstein D, Sethi S, Nava MB, Barisoni L, Fervenza FC, Kopp JB
Source: Am J Nephrol 2019;49(5):377-385
Publication date: 2019
The relationship between thyroid dysfunction and nephrotic syndrome: a clinicopathological study.
Author(s): Li LZ, Hu Y, Ai SL, Cheng L, Liu J, Morris E, Li Y, Gou SJ, Fu P
Source: Sci Rep 2019 Apr 23;9(1):6421
Publication date: 2019-04-23
Nephritic Factors: An Overview of Classification, Diagnostic Tools and Clinical Associations.
Author(s): Corvillo F, Okrój M, Nozal P, Melgosa M, Sánchez-Corral P, López-Trascasa M
Source: Front Immunol 2019;10:886
Publication date: 2019
C3-Glomerulopathy Autoantibodies Mediate Distinct Effects on Complement C3- and C5-Convertases.
Author(s): Zhao F, Afonso S, Lindner S, Hartmann A, Löschmann I, Nilsson B, Ekdahl KN, Weber LT, Habbig S, Schalk G, Kirschfink M, Zipfel PF, Skerka C
Source: Front Immunol 2019;10:1030
Publication date: 2019
Gremlin, A Potential Urinary Biomarker of Anca-Associated Crescentic Glomerulonephritis.
Author(s): Droguett A, Valderrama G, Burgos ME, Carpio D, Saka C, Egido J, Ruiz-Ortega M, Mezzano S
Source: Sci Rep 2019 May 3;9(1):6867
Publication date: 2019-05-3
Prognostic Value of Microscopic Hematuria after Induction of Remission in Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis.
Author(s): Vandenbussche C, Bitton L, Bataille P, Glowacki F, Azar R, Hatron PY, Macnamara E, Gheerbrant JD, Cardon G, Hoffmann M, Auxenfants E, Gnemmi V, Quéméneur T
Source: Am J Nephrol 2019;49(6):479-486
Publication date: 2019
Low-dose cyclosporine for active lupus nephritis: a dose titration approach.
Author(s): Sumethkul K, Kitumnuaypong T, Angthararak S, Pichaiwong W
Source: Clin Rheumatol 2019 Apr 1;
Publication date: 2019-04-1
Combination immunosuppressant therapy and lupus nephritis outcome: a hospital-based study.
Author(s): Chen YM, Hung WT, Liao YW, Hsu CY, Hsieh TY, Chen HH, Hsieh CW, Lin CT, Lai KL, Tang KT, Tseng CW, Huang WN, Chen YH
Source: Lupus 2019 Apr;28(5):658-666
Publication date: 2019-04
Treatment Options for Refractory Lupus Nephritis.
Author(s): Anders HJ, Hiepe F
Source: Clin J Am Soc Nephrol 2019 May 7;14(5):653-655
Publication date: 2019-05-7
Renal transplantation for lupus nephritis: non-adherence and graft survival.
Author(s): Ntatsaki E, Vassiliou VS, Velo-Garcia A, Salama AD, Isenberg DA
Source: Lupus 2019 Apr;28(5):651-657
Publication date: 2019-04
Basophil involvement in lupus nephritis: a basis for innovation in daily care.
Author(s): Charles N, Chemouny JM, Daugas E
Source: Nephrol Dial Transplant 2019 May 1;34(5):750-756
Publication date: 2019-05-1
The behavior of neutrophil extracellular traps and NADPH oxidative activity in pediatric systemic lupus erythematosus: relation to disease activity and lupus nephritis.
Author(s): El-Ghoneimy DH, Hesham M, Hasan R, Tarif M, Gouda S
Source: Clin Rheumatol 2019 Apr 27;
Publication date: 2019-04-27
Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Author(s): Adhya Z, El Anbari M, Anwar S, Mortimer A, Marr N, Karim MY
Source: Lupus 2019 May;28(6):713-721
Publication date: 2019-05
Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial.
Author(s): Singh JA, Fraenkel L, Green C, Alarcón GS, Barton JL, Saag KG, Hanrahan LM, Raymond SC, Kimberly RP, Leong AL, Reyes E, Street RL Jr, Suarez-Almazor ME, Eakin GS, Marrow L, Morgan CJ, Caro B, Sloan JA, Jandali B, Garcia SR, Grossman J, Winthrop KL, Trupin L, Dall'Era M, Meara A, Rizvi T, Chatham WW, Yazdany J
Source: PLoS Med 2019 May;16(5):e1002800
Publication date: 2019-05
Pregnancy outcome in women with active and inactive lupus nephritis: A prospective cohort study.
Author(s): Attia DH, Mokbel A, Haggag HM, Naeem N
Source: Lupus 2019 Jun;28(7):806-817
Publication date: 2019-06
Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways.
Author(s): Der E, Suryawanshi H, Morozov P, Kustagi M, Goilav B, Ranabathou S, Izmirly P, Clancy R, Belmont HM, Koenigsberg M, Mokrzycki M, Rominieki H, Graham JA, Rocca JP, Bornkamp N, Jordan N, Schulte E, Wu M, Pullman J, Slowikowski K, Raychaudhuri S, Guthridge J, James J, Buyon J, Tuschl T, Putterman C
Source: Nat Immunol 2019 Jul;20(7):915-927
Publication date: 2019-07
Pathogenesis of lupus nephritis: RIP3 dependent necroptosis and NLRP3 inflammasome activation.
Author(s): Guo C, Fu R, Zhou M, Wang S, Huang Y, Hu H, Zhao J, Gaskin F, Yang N, Fu SM
Source: J Autoimmun 2019 May 24;
Publication date: 2019-05-24
Is serum uric acid a predictor of long-term renal outcome in lupus nephritis?
Author(s): Ugolini-Lopes MR, Gavinier SS, Leon E, Viana VT, Borba EF, Bonfá E
Source: Clin Rheumatol 2019 Jun 2;
Publication date: 2019-06-2
Transplantation of dental tissue-derived mesenchymal stem cells ameliorates nephritis in lupus mice.
Author(s): Tang X, Li W, Wen X, Zhang Z, Chen W, Yao G, Chen H, Wang D, Shi S, Sun L
Source: Ann Transl Med 2019 Apr;7(7):132
Publication date: 2019-04
Single-cell analysis identifies key pathways and prognostic markers in lupus nephritis.
Author(s): Carney EF
Source: Nat Rev Rheumatol 2019 Jun 5;
Publication date: 2019-06-5
The human glomerular endothelial cells are potent pro-inflammatory contributors in an in vitro model of lupus nephritis.
Author(s): Dimou P, Wright RD, Budge KL, Midgley A, Satchell SC, Peak M, Beresford MW
Source: Sci Rep 2019 Jun 6;9(1):8348
Publication date: 2019-06-6
The expression of NOD2, NLRP3 and NLRC5 and renal injury in anti-neutrophil cytoplasmic antibody-associated vasculitis.
Author(s): Wang LY, Sun XJ, Chen M, Zhao MH
Source: J Transl Med 2019 Jun 11;17(1):197
Publication date: 2019-06-11
Real-world electronic health record identifies antimalarial underprescribing in patients with lupus nephritis.
Author(s): Xiong WW, Boone JB, Wheless L, Chung CP, Crofford LJ, Barnado A
Source: Lupus 2019 Jun 12;:961203319856088
Publication date: 2019-06-12
Nephropathic autoantigens in the spectrum of lupus nephritis.
Author(s): Anders HJ
Source: Nat Rev Nephrol 2019 Jun 13;
Publication date: 2019-06-13
The immune cell landscape in kidneys of patients with lupus nephritis.
Author(s): Arazi A, Rao DA, Berthier CC, Davidson A, Liu Y, Hoover PJ, Chicoine A, Eisenhaure TM, Jonsson AH, Li S, Lieb DJ, Zhang F, Slowikowski K, Browne EP, Noma A, Sutherby D, Steelman S, Smilek DE, Tosta P, Apruzzese W, Massarotti E, Dall'Era M, Park M, Kamen DL, Furie RA, Payan-Schober F, Pendergraft WF 3rd, McInnis EA, Buyon JP, Petri MA, Putterman C, Kalunian KC, Woodle ES, Lederer JA, Hildeman DA, Nusbaum C, Raychaudhuri S, Kretzler M, Anolik JH, Brenner MB, Wofsy D, Hacohen N, Diamond B
Source: Nat Immunol 2019 Jul;20(7):902-914
Publication date: 2019-07
Pharmacokinetics of enteric coated mycophenolate sodium in lupus nephritis (POEMSLUN).
Author(s): Ranganathan D, Abdul-Aziz MH, John GT, McWhinney BC, Fassett RG, Healy H, Kubler P, Lim A, Lipman J, Purvey M, Roberts M, Reyaldeen R, Ungerer J, Roberts JA
Source: Ther Drug Monit 2019 Jun 18;
Publication date: 2019-06-18
Impact of Induction Immunosuppression on the Recurrence of Primary IgA Nephropathy.
Author(s): Lee KW, Kim KS, Lee JS, Yoo H, Kim K, Park JB, Kwon GY, Kim SJ
Source: Transplant Proc 2019 Jun;51(5):1491-1495
Publication date: 2019-06
High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
Author(s): Gong WY, Liu M, Luo D, Liu FN, Yin LH, Li YQ, Zhang J, Peng H
Source: BMC Nephrol 2019 Apr 30;20(1):150
Publication date: 2019-04-30
Genetic Variations rs859, rs4646, and rs372883 in the 3'-Untranslated Regions of Genes Are Associated with a Risk of IgA Nephropathy.
Author(s): Yang X, Jin G, Zhang Y, Xie M, Li W, Zhang D, Wang R, Zhang P, Han Y, Wei J
Source: Kidney Blood Press Res 2019;44(2):233-244
Publication date: 2019
Updated Oxford classification and the international study of kidney disease in children classification: application in predicting outcome of Henoch-Schönlein purpura nephritis.
Author(s): Huang X, Ma L, Ren P, Wang H, Chen L, Han H, Chen J, Han F
Source: Diagn Pathol 2019 May 10;14(1):40
Publication date: 2019-05-10
M2a and M2b macrophages predominate in kidney tissues and M2 subpopulations were associated with the severity of disease of IgAN patients.
Author(s): Hu W, Lin J, Lian X, Yu F, Liu W, Wu Y, Fang X, Liang X, Hao W
Source: Clin Immunol 2019 May 9;205:8-15
Publication date: 2019-05-9
A proliferation-inducing ligand (APRIL) induced hyper-production of IgA from tonsillar mononuclear cells in patients with IgA nephropathy.
Author(s): Takahara M, Nagato T, Nozaki Y, Kumai T, Katada A, Hayashi T, Harabuchi Y
Source: Cell Immunol 2019 Jul;341:103925
Publication date: 2019-07
Association Between Tonsillectomy and Outcomes in Patients With Immunoglobulin A Nephropathy.
Author(s): Hirano K, Matsuzaki K, Yasuda T, Nishikawa M, Yasuda Y, Koike K, Maruyama S, Yokoo T, Matsuo S, Kawamura T, Suzuki Y
Source: JAMA Netw Open 2019 May 3;2(5):e194772
Publication date: 2019-05-3
Markers of renal fibrosis: How do they correlate with podocyte damage in glomerular diseases?
Author(s): Lopes TG, de Souza ML, da Silva VD, Dos Santos M, da Silva WIC, Itaquy TP, Garbin HI, Veronese FV
Source: PLoS One 2019;14(6):e0217585
Publication date: 2019
Association of ITGAX and ITGAM gene polymorphisms with susceptibility to IgA nephropathy.
Author(s): Shi D, Zhong Z, Xu R, Li B, Li J, Habib U, Peng Y, Mao H, Li Z, Huang F, Yu X, Li M
Source: J Hum Genet 2019 Jun 21;
Publication date: 2019-06-21
Machine Learning in Glomerular Diseases: Promise for Precision Medicine.
Author(s): Nadkarni GN, Chaudhary K, Coca SG
Source: Am J Kidney Dis 2019 Jun 11;
Publication date: 2019-06-11
Renal Vasculitis and Pauci-immune Glomerulonephritis Associated With Immune Checkpoint Inhibitors.
Author(s): Gallan AJ, Alexander E, Reid P, Kutuby F, Chang A, Henriksen KJ
Source: Am J Kidney Dis 2019 Jun 13;
Publication date: 2019-06-13
Mesangial Deposition Can Strongly Involve Innate-Like IgA Molecules Lacking Affinity Maturation.
Author(s): Wehbi B, Oblet C, Boyer F, Huard A, Druilhe A, Paraf F, Cogné E, Moreau J, El Makhour Y, Badran B, Van Egmond M, Cogné M, Aldigier JC
Source: J Am Soc Nephrol 2019 Jun 21;
Publication date: 2019-06-21
Proteomic analysis of neutrophils in ANCA-associated vasculitis reveals a dysregulation in proteinase 3-associated proteins such as annexin-A1 involved in apoptotic cell clearance.
Author(s): Everts-Graber J, Martin KR, Thieblemont N, Mocek J, Roccabianca A, Chafey P, Le Gall M, Tacnet-Delorme P, Reutelingsperger CP, Naccache JM, Bonnotte B, Karras A, Puéchal X, Guillevin L, Terrier B, Frachet P, Perretti M, Mouthon L, Witko-Sarsat V
Source: Kidney Int 2019 Mar 4;
Publication date: 2019-03-4
Plasma Zonulin Levels in Childhood Nephrotic Syndrome.
Author(s): Trachtman H, Gipson DS, Lemley KV, Troost JP, Faul C, Morrison DJ, Vento SM, Ahn DH, Goldberg JD
Source: Front Pediatr 2019;7:197
Publication date: 2019
Protein convertase subtilisin/kexin type 9 biology in nephrotic syndrome: implications for use as therapy.
Author(s): Busuioc RM, Covic A, Kanbay M, Banach M, Burlacu A, Mircescu G
Source: Nephrol Dial Transplant 2019 Jun 3;
Publication date: 2019-06-3
Safety and effectiveness of transjugular renal biopsy for systemic lupus erythematosus and antiphospholipid antibody syndrome patients taking antithrombotics.
Author(s): Nielly H, Mathian A, Cazenave M, Izzedine H, Haroche J, Cohen-Aubart F, Hie M, Miyara M, Pineton de Chambrun M, Benameur N, Hausfater P, Pha M, Boutin-Lê Thi Huong D, Rouvier P, Brocheriou I, Cluzel P, Amoura Z
Source: Nephrol Dial Transplant 2019 Jun 3;
Publication date: 2019-06-3
Pediatric Patients With Steroid-Sensitive Nephrotic Syndrome Have Higher Expression of T Regulatory Lymphocytes in Comparison to Steroid-Resistant Disease.
Author(s): Guimarães FTL, Ferreira RN, Brito-Melo GEA, Rocha-Vieira E, Pereira WF, Pinheiro SVB, Miranda AS, Simões E Silva AC
Source: Front Pediatr 2019;7:114
Publication date: 2019
Serum levels of DNAJB9 are elevated in fibrillary glomerulonephritis patients.
Author(s): Nasr SH, Dasari S, Lieske JC, Benson LM, Vanderboom PM, Holtz-Heppelmann CJ, Giesen CD, Snyder MR, Erickson SB, Fervenza FC, Leung N, Kurtin PJ, Alexander MP
Source: Kidney Int 2019 May;95(5):1269-1272
Publication date: 2019-05
Circulating factors cause proteinuria in parabiotic zebrafish.
Author(s): Müller-Deile J, Schenk H, Schroder P, Schulze K, Bolaños-Palmieri P, Siegerist F, Endlich N, Haller H, Schiffer M
Source: Kidney Int 2019 Mar 8;
Publication date: 2019-03-8
A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy.
Author(s): Myette JR, Kano T, Suzuki H, Sloan SE, Szretter KJ, Ramakrishnan B, Adari H, Deotale KD, Engler F, Shriver Z, Wollacott AM, Suzuki Y, Pereira BJG
Source: Kidney Int 2019 Mar 16;
Publication date: 2019-03-16
Randomized controlled trial on immunomodulatory effects of azithromycin in children with steroid-dependent nephrotic syndrome.
Author(s): Sawires H, Abdelaziz H, Ahmed HM, Botrous O, Agban M
Source: Pediatr Nephrol 2019 May 15;
Publication date: 2019-05-15
Microangiopathic Lesions in IgA Nephropathy: A Cohort Study.
Author(s): Cai Q, Shi S, Wang S, Ren Y, Hou W, Liu L, Lv J, Haas M, Zhang H
Source: Am J Kidney Dis 2019 May 15;
Publication date: 2019-05-15
Assessing the relative impact of lupus nephritis on mortality in a population-based systemic lupus erythematosus cohort.
Author(s): Reppe Moe SE, Molberg Ø, Strøm EH, Lerang K
Source: Lupus 2019 May 9;:961203319847275
Publication date: 2019-05-9
Epidemiology and clinical features of childhood-onset anti-neutrophil cytoplasmic antibody-associated vasculitis: a clinicopathological analysis.
Author(s): Hirano D, Ishikawa T, Inaba A, Sato M, Shinozaki T, Iijima K, Ito S
Source: Pediatr Nephrol 2019 May 10;
Publication date: 2019-05-10
Exostosin 1/Exostosin 2-Associated Membranous Nephropathy.
Author(s): Sethi S, Madden BJ, Debiec H, Charlesworth MC, Gross L, Ravindran A, Hummel AM, Specks U, Fervenza FC, Ronco P
Source: J Am Soc Nephrol 2019 May 6;
Publication date: 2019-05-6
Clinical importance of the updated Oxford classification in allograft IgA nephropathy.
Author(s): Park S, Go H, Baek CH, Kim YH, Kim YC, Yang SH, Lee JP, Min SI, Ha J, Song EY, Kim YS, Park SK, Lee H, Moon KC
Source: Am J Transplant 2019 Apr 24;
Publication date: 2019-04-24
Prediction and Risk Stratification of Kidney Outcomes in IgA Nephropathy.
Author(s): Chen T, Li X, Li Y, Xia E, Qin Y, Liang S, Xu F, Liang D, Zeng C, Liu Z
Source: Am J Kidney Dis 2019 Apr 25;
Publication date: 2019-04-25
Antimalarials in IgA Nephropathy: Did Our Supportive Therapy Armamentarium Just Increase?
Author(s): Floege J
Source: Am J Kidney Dis 2019 Apr 17;
Publication date: 2019-04-17
A newly established clinical registry of minimal change disease and focal and segmental glomerulosclerosis in Germany.
Author(s): Völker LA, Ehren R, Grundmann F, Benzing T, Weber LT, Brinkkötter PT
Source: Nephrol Dial Transplant 2019 Apr 21;
Publication date: 2019-04-21
Autologous Hematopoietic Stem Cell Transplantation for Refractory Lupus Nephritis.
Author(s): Huang X, Chen W, Ren G, Zhao L, Guo J, Gong D, Zeng C, Hu W, Liu Z
Source: Clin J Am Soc Nephrol 2019 Apr 12;
Publication date: 2019-04-12
Association of low birth weight and prematurity with clinical outcomes of childhood nephrotic syndrome: a prospective cohort study.
Author(s): Konstantelos N, Banh T, Patel V, Vasilevska-Ristovska J, Borges K, Hussain-Shamsy N, Noone D, Hebert D, Radhakrishnan S, Licht CPB, Langlois V, Pearl RJ, Parekh RS
Source: Pediatr Nephrol 2019 Apr 11;
Publication date: 2019-04-11
Mortality in IgA Nephropathy: A Nationwide Population-Based Cohort Study.
Author(s): Jarrick S, Lundberg S, Welander A, Carrero JJ, Höijer J, Bottai M, Ludvigsson JF
Source: J Am Soc Nephrol 2019 Apr 10;
Publication date: 2019-04-10
Methylprednisolone or cyclosporine a in the treatment of Henoch-Schönlein nephritis: a nationwide study.
Author(s): Koskela M, Jahnukainen T, Endén K, Arikoski P, Kataja J, Nuutinen M, Ylinen E
Source: Pediatr Nephrol 2019 Apr 6;
Publication date: 2019-04-6
Quality Improvement Initiative to Reduce Admissions for Nephrotic Syndrome Relapse in Pediatric Patients.
Author(s): Charnaya O, Ahn SY
Source: Front Pediatr 2019;7:112
Publication date: 2019
Treatment of nephrotic syndrome: going beyond immunosuppressive therapy.
Author(s): Zhao J, Liu Z
Source: Pediatr Nephrol 2019 Mar 23;
Publication date: 2019-03-23
Clinical impact of endocapillary proliferation with modified cutoff points in IgA nephropathy patients.
Author(s): Kaihan AB, Yasuda Y, Imaizumi T, Inagaki K, Ozeki T, Hishida M, Katsuno T, Tsuboi N, Maruyama S
Source: PLoS One 2019;14(3):e0214414
Publication date: 2019
Complete renal response at 12 months after induction therapy is associated with renal relapse-free rate in lupus nephritis: a single-center, retrospective cohort study.
Author(s): Ichinose K, Kitamura M, Sato S, Eguchi M, Okamoto M, Endo Y, Tsuji S, Takatani A, Shimizu T, Umeda M, Fukui S, Sumiyoshi R, Koga T, Kawashiri S, Iwamoto N, Igawa T, Tamai M, Nakamura H, Origuchi T, Nishino T, Kawakami A
Source: Lupus 2019 Apr;28(4):501-509
Publication date: 2019-04
Antibodies to M-type phospholipase A2 receptor (PLA2R) in membranous lupus nephritis.
Author(s): Garcia-Vives E, Solé C, Moliné T, Alvarez-Rios AM, Vidal M, Agraz I, Ordi-Ros J, Cortés-Hernández J
Source: Lupus 2019 Mar;28(3):396-405
Publication date: 2019-03
Renal Outcomes of Pregnant Patients with Immunoglobulin A Nephropathy: A Systematic Review and Meta-Analysis.
Author(s): Wang F, Lu JD, Zhu Y, Wang TT, Xue J
Source: Am J Nephrol 2019;49(3):214-224
Publication date: 2019
Hepcidin and arterial stiffness in children with systemic lupus erythematosus and lupus nephritis: A cross-sectional study.
Author(s): Atkinson MA, Joo S, Sule S
Source: PLoS One 2019;14(3):e0214248
Publication date: 2019
C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial.
Author(s): Ruggenenti P, Daina E, Gennarini A, Carrara C, Gamba S, Noris M, Rubis N, Peraro F, Gaspari F, Pasini A, Rigotti A, Lerchner RM, Santoro D, Pisani A, Pasi A, Remuzzi G
Source: Am J Kidney Dis 2019 Mar 28;
Publication date: 2019-03-28
Predictors of rituximab-related neutropenia in Japanese children with steroid-dependent nephrotic syndrome.
Author(s): Fujinaga S, Tomii Y
Source: Pediatr Nephrol 2019 Mar 18;
Publication date: 2019-03-18
Neurological complications in childhood nephrotic syndrome: A systematic review.
Author(s): Stabouli S, Chrysaidou K, Kupferman JC, Zafeiriou DI
Source: Eur J Paediatr Neurol 2019 Feb 22;
Publication date: 2019-02-22
Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis.
Author(s): Smith E, Al-Abadi E, Armon K, Bailey K, Ciurtin C, Davidson J, Gardner-Medwin J, Haslam K, Hawley D, Leahy A, Leone V, McErlane F, Mewar D, Modgil G, Moots R, Pilkington C, Ramanan A, Rangaraj S, Riley P, Sridhar A, Wilkinson N, Beresford MW, Hedrich CM
Source: Lupus 2019 Mar 14;:961203319836712
Publication date: 2019-03-14
Rituximab bioavailability in primary membranous nephropathy.
Author(s): Boyer-Suavet S, Andreani M, Cremoni M, Brglez V, Benzaken S, Bernard G, Nachman P, Esnault V, Seitz-Polski B
Source: Nephrol Dial Transplant 2019 Mar 30;
Publication date: 2019-03-30
Clinical course and outcome after kidney transplantation in patients with C3 glomerulonephritis due to CFHR5 nephropathy.
Author(s): Frangou E, Varnavidou-Nicolaidou A, Petousis P, Soloukides A, Theophanous E, Savva I, Michael N, Toumasi E, Georgiou D, Stylianou G, Mean R, Anastasiadou N, Athanasiou Y, Zavros M, Kyriacou K, Deltas C, Hadjianastassiou V
Source: Nephrol Dial Transplant 2019 Mar 7;
Publication date: 2019-03-7
IgA nephropathy: is a new approach beyond proteinuria necessary?
Author(s): Gutiérrez E
Source: Pediatr Nephrol 2019 Feb 18;
Publication date: 2019-02-18
Nephrotic syndrome in a dish: recent developments in modeling in vitro.
Author(s): Veissi S, Smeets B, van den Heuvel LP, Schreuder MF, Jansen J
Source: Pediatr Nephrol 2019 Feb 28;
Publication date: 2019-02-28
Should proteinase-3 and myeloperoxidase-anti-neutrophil cytoplasmic antibody vasculitis be treated differently: part 2.
Author(s): Cohen Tervaert JW
Source: Nephrol Dial Transplant 2019 Jan 21;
Publication date: 2019-01-21
The Oxford Classification for immunoglobulin A nephropathy: a common language blurred by dissonant voices.
Author(s): Maillard N, Mariat C
Source: Nephrol Dial Transplant 2019 Feb 18;
Publication date: 2019-02-18
Dynamic Thiol/Disulphide Homeostasis in Children with Nephrotic Syndrome.
Author(s): Yazılıtaş F, Oztek-Celebi FZ, Erel Ö, Çakıcı EK, Alışık M, Bülbül M
Source: Nephron 2019 Feb 6;:1-9
Publication date: 2019-02-6
Prevalence of Asthma and Allergies and Risk of Relapse in Childhood Nephrotic Syndrome: Insight into Nephrotic Syndrome Cohort.
Author(s): Riar SS, Banh THM, Borges K, Subbarao P, Patel V, Vasilevska-Ristovska J, Chanchlani R, Hussain-Shamsy N, Noone D, Hebert D, Licht CPB, Langlois V, Pearl RJ, Parekh RS
Source: J Pediatr 2019 Feb 4;
Publication date: 2019-02-4
Expression of vitamin D receptor in renal tissue of lupus nephritis and its association with renal injury activity.
Author(s): Sun J, Zhang S, Liu JS, Gui M, Zhang H
Source: Lupus 2019 Jan 28;:961203319826704
Publication date: 2019-01-28
Podocytopathy in the mesangial proliferative immunoglobulin A nephropathy: new insights into the mechanisms of damage and progression.
Author(s): Trimarchi H, Coppo R
Source: Nephrol Dial Transplant 2019 Jan 29;
Publication date: 2019-01-29
Early-stage predictors for treatment responses in patients with active lupus nephritis.
Author(s): Liu G, Wang H, Le J, Lan L, Xu Y, Yang Y, Chen J, Han F
Source: Lupus 2019 Jan 25;:961203319826703
Publication date: 2019-01-25
Should proteinase 3 and myeloperoxidase antineutrophil cytoplasmic antibody vasculitis be treated differently: part 1.
Author(s): Watts RA
Source: Nephrol Dial Transplant 2019 Jan 21;
Publication date: 2019-01-21
Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis.
Author(s): Wilson HR, Medjeral-Thomas NR, Gilmore AC, Trivedi P, Seyb K, Farzaneh-Far R, Gunnarsson I, Zickert A, Cairns TD, Lightstone L, Cook HT, Pickering MC
Source: Kidney Int 2019 Jan 8;
Publication date: 2019-01-8
Estimating the epidemiology of anti-neutrophil cytoplasm antibody-associated renal vasculitis and the role of histologic chronicity in predicting renal outcomes.
Author(s): Kronbichler A, Jayne DRW
Source: Nephrol Dial Transplant 2019 Jan 14;
Publication date: 2019-01-14
Clinical and histopathological prognostic factors affecting the renal outcomes in childhood ANCA-associated vasculitis.
Author(s): Özçelik G, Sönmez HE, Şahin S, Özağarı A, Bayram MT, Çiçek RY, Çakıcı EK, Çomak E, Barut K, Şahin N, Bakkaloğlu S, Gökçe İ, Düzova A, Bilginer Y, Açarı C, Melek E, Kılıç BD, Özdel S, Adroviç A, Kasapçopur Ö, Ünsal E, Alpay H, Orhan D, Topaloğlu R, Düşünsel R, Özen S
Source: Pediatr Nephrol 2019 Jan 4;
Publication date: 2019-01-4
IL-34-Dependent Intrarenal and Systemic Mechanisms Promote Lupus Nephritis in MRL-Faslpr Mice.
Author(s): Wada Y, Gonzalez-Sanchez HM, Weinmann-Menke J, Iwata Y, Ajay AK, Meineck M, Kelley VR
Source: J Am Soc Nephrol 2019 Jan 8;
Publication date: 2019-01-8
Long-term outcome of kidney transplantation in AL amyloidosis.
Author(s): Angel-Korman A, Stern L, Sarosiek S, Sloan JM, Doros G, Sanchorawala V, Havasi A
Source: Kidney Int 2018 Dec 20;
Publication date: 2018-12-20
Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort.
Author(s): Bellur SS, Roberts ISD, Troyanov S, Royal V, Coppo R, Cook HT, Cattran D, Arce Terroba Y, Asunis AM, Bajema I, Bertoni E, Bruijn JA, Cannata-Ortiz P, Casartelli D, Maria Di Palma A, Ferrario F, Fortunato M, Furci L, Gakiopoulou H, Galesic Ljubanovic D, Giannakakis K, Gomà M, Gröne HJ, Gutiérrez EM, Asma Haider S, Honsova E, Ioachim E, Karkoszka H, Kipgen D, Maldyk J, Mazzucco G, Orhan D, Ozluk Y, Pantzaki A, Perkowska-Ptasinska A, Riispere Z, Soderberg MP, Steenbergen E, Stoppacciaro A, Sundelin Von Feilitzen B, Tardanico R
Source: Nephrol Dial Transplant 2018 Dec 15;
Publication date: 2018-12-15
Low-dose rituximab is no less effective for nephrotic syndrome measured by 12-month outcome.
Author(s): Maxted AP, Dalrymple RA, Chisholm D, McColl J, Tse Y, Christian MT, Reynolds BC
Source: Pediatr Nephrol 2018 Dec 18;
Publication date: 2018-12-18
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.
Author(s): Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P, D'Agati VD, Dispenzieri A, Fervenza FC, Fermand JP, Gibbs S, Gillmore JD, Herrera GA, Jaccard A, Jevremovic D, Kastritis E, Kukreti V, Kyle RA, Lachmann HJ, Larsen CP, Ludwig H, Markowitz GS, Merlini G, Mollee P, Picken MM, Rajkumar VS, Royal V, Sanders PW, Sethi S, Venner CP, Voorhees PM, Wechalekar AD, Weiss BM, Nasr SH
Source: Nat Rev Nephrol 2019 Jan;15(1):45-59
Publication date: 2019-01
Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children.
Author(s): Kamei K, Ishikura K, Sako M, Ito S, Nozu K, Iijima K
Source: Pediatr Nephrol 2018 Dec 18;
Publication date: 2018-12-18
Cardiovascular, thromboembolic and renal outcomes in IgA vasculitis (Henoch-Schönlein purpura): a retrospective cohort study using routinely collected primary care data.
Author(s): Tracy A, Subramanian A, Adderley NJ, Cockwell P, Ferro C, Ball S, Harper L, Nirantharakumar K
Source: Ann Rheum Dis 2018 Nov 28;
Publication date: 2018-11-28
Late-onset biopsy-proven lupus nephritis without other associated autoimmune diseases: severity and long-term outcome.
Author(s): Ugolini-Lopes MR, Santos LPS, Stagnaro C, Seguro LPC, Mosca M, Bonfá E
Source: Lupus 2018 Nov 15;:961203318811603
Publication date: 2018-11-15
Plasma cytokines as potential biomarkers of kidney damage in patients with systemic lupus erythematosus.
Author(s): Pacheco-Lugo L, Sáenz-García J, Navarro Quiroz E, González Torres H, Fang L, Díaz-Olmos Y, Garavito de Egea G, Egea Bermejo E, Aroca Martínez G
Source: Lupus 2018 Nov 19;:961203318812679
Publication date: 2018-11-19
Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Author(s): Sinha A, Puraswani M, Kalaivani M, Goyal P, Hari P, Bagga A
Source: Kidney Int 2018 Nov 22;
Publication date: 2018-11-22
Towards a personalized treatment for IgA nephropathy considering pathology and pathogenesis.
Author(s): Coppo R
Source: Nephrol Dial Transplant 2018 Nov 26;
Publication date: 2018-11-26
Childhood onset steroid-sensitive nephrotic syndrome continues into adulthood.
Author(s): Korsgaard T, Andersen RF, Joshi S, Hagstrøm S, Rittig S
Source: Pediatr Nephrol 2018 Nov 13;
Publication date: 2018-11-13
Adrenocorticotropic Hormone for Childhood Nephrotic Syndrome: The ATLANTIS Randomized Trial.
Author(s): Wang CS, Travers C, McCracken C, Leong T, Gbadegesin R, Quiroga A, Benfield MR, Hidalgo G, Srivastava T, Lo M, Yadin O, Mathias R, Araya CE, Khalid M, Orjuela A, Zaritsky J, Al-Akash S, Kamel M, Greenbaum LA
Source: Clin J Am Soc Nephrol 2018 Nov 15;
Publication date: 2018-11-15
Long-term outcomes after early treatment with rituximab for Japanese children with cyclosporine- and steroid-resistant nephrotic syndrome.
Author(s): Fujinaga S, Nishino T, Umeda C, Tomii Y, Watanabe Y, Sakuraya K
Source: Pediatr Nephrol 2018 Nov 13;
Publication date: 2018-11-13
Modulation of the microbiota by oral antibiotics treats immunoglobulin A nephropathy in humanized mice.
Author(s): Chemouny JM, Gleeson PJ, Abbad L, Lauriero G, Boedec E, Le Roux K, Monot C, Bredel M, Bex-Coudrat J, Sannier A, Daugas E, Vrtovsnik F, Gesualdo L, Leclerc M, Berthelot L, Ben Mkaddem S, Lepage P, Monteiro RC
Source: Nephrol Dial Transplant 2018 Nov 20;
Publication date: 2018-11-20
Correlation between endocapillary proliferative and nephrotic-range proteinuria in children with Henoch-Schönlein purpura nephritis.
Author(s): Yang XQ, Huang YJ, Zhai WS, Ren XQ, Guo QY, Zhang X, Yang M, Zhang J, Ding Y, Zhu S, Yamamoto T, Sun Y
Source: Pediatr Nephrol 2018 Nov 10;
Publication date: 2018-11-10
Repeat renal biopsy improves the Oxford classification-based prediction of immunoglobulin A nephropathy outcome.
Author(s): Jullien P, Laurent B, Berthoux F, Masson I, Dinic M, Claisse G, Thibaudin D, Mariat C, Alamartine E, Maillard N
Source: Nephrol Dial Transplant 2018 Nov 15;
Publication date: 2018-11-15
Growing international evidence for urinary biomarker panels identifying lupus nephritis in children - verification within the South African Paediatric Lupus Cohort.
Author(s): Smith EMD, Lewandowski LB, Jorgensen AL, Phuti A, Nourse P, Scott C, Beresford MW
Source: Lupus 2018 Oct 22;:961203318808376
Publication date: 2018-10-22
Effectiveness of renoprotective approaches for persistent proteinuria in lupus nephritis: more than just immunosuppression.
Author(s): Castro M, Ugolini-Lopes M, Borba EF, Bonfá E, Seguro LPC
Source: Lupus 2018 Nov 4;:961203318809883
Publication date: 2018-11-4
Zonal cortical scarring and tubular thyroidization in kidney biopsies of patients with SLE-histologic indicator for antiphospholipid antibodies.
Author(s): Shah R, Brodsky SV, Hebert L, Rovin BH, Nadasdy T, Satoskar AA
Source: Lupus 2018 Nov 7;:961203318809177
Publication date: 2018-11-7
An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study).
Author(s): Rémy P, Audard V, Natella PA, Pelle G, Dussol B, Leray-Moragues H, Vigneau C, Bouachi K, Dantal J, Vrigneaud L, Karras A, Pourcine F, Gatault P, Grimbert P, Ait Sahlia N, Moktefi A, Daugas E, Rigothier C, Bastuji-Garin S, Sahali D
Source: Kidney Int 2018 Oct 20;
Publication date: 2018-10-20
Kidney diseases associated with Waldenström macroglobulinemia.
Author(s): Uppal NN, Monga D, Vernace MA, Mehtabdin K, Shah HH, Bijol V, Jhaveri KD
Source: Nephrol Dial Transplant 2018 Oct 31;
Publication date: 2018-10-31
Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis.
Author(s): Moran SM, Monach PA, Zgaga L, Cuthbertson D, Carette S, Khalidi NA, Koening CL, Langford CA, McAlear CA, Moreland L, Pagnoux C, Seo P, Specks U, Sreih A, Wyse J, Ytterberg SR, Merkel PA, Little MA
Source: Nephrol Dial Transplant 2018 Oct 31;
Publication date: 2018-10-31
Anti-glomerular basement membrane disease: an update on subgroups, pathogenesis and therapies.
Author(s): Segelmark M, Hellmark T
Source: Nephrol Dial Transplant 2018 Oct 29;
Publication date: 2018-10-29
Development and validation of a renal risk score in ANCA-associated glomerulonephritis.
Author(s): Brix SR, Noriega M, Tennstedt P, Vettorazzi E, Busch M, Nitschke M, Jabs WJ, Özcan F, Wendt R, Hausberg M, Sellin L, Panzer U, Huber TB, Waldherr R, Hopfer H, Stahl RAK, Wiech T
Source: Kidney Int 2018 Oct 23;
Publication date: 2018-10-23
Properdin binds independent of complement activation in an in vivo model of anti-glomerular basement membrane disease.
Author(s): O'Flynn J, Kotimaa J, Faber-Krol R, Koekkoek K, Klar-Mohamad N, Koudijs A, Schwaeble WJ, Stover C, Daha MR, van Kooten C
Source: Kidney Int 2018 Oct 10;
Publication date: 2018-10-10
Pharmacokinetics and pharmacogenomics of mycophenolic acid and its clinical correlations in maintenance immunosuppression for lupus nephritis.
Author(s): Yap DYH, Tam CH, Yung S, Wong S, Tang CSO, Mok TMY, Yuen CKY, Ma MKM, Lau CS, Chan TM
Source: Nephrol Dial Transplant 2018 Sep 11;
Publication date: 2018-09-11
Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study).
Author(s): Shima Y, Nakanishi K, Sako M, Saito-Oba M, Hamasaki Y, Hataya H, Honda M, Kamei K, Ishikura K, Ito S, Kaito H, Tanaka R, Nozu K, Nakamura H, Ohashi Y, Iijima K, Yoshikawa N
Source: Pediatr Nephrol 2018 Oct 3;
Publication date: 2018-10-3
Treatment of steroid-resistant nephrotic syndrome in the genomic era.
Author(s): Bensimhon AR, Williams AE, Gbadegesin RA
Source: Pediatr Nephrol 2018 Oct 2;
Publication date: 2018-10-2
B cell phenotype in pediatric idiopathic nephrotic syndrome.
Author(s): Colucci M, Carsetti R, Cascioli S, Serafinelli J, Emma F, Vivarelli M
Source: Pediatr Nephrol 2018 Sep 28;
Publication date: 2018-09-28
Clinical predictors of active LN development in children - evidence from the UK JSLE Cohort Study.
Author(s): Smith EMD, Yin P, Jorgensen AL, Beresford MW
Source: Lupus 2018 Sep 23;:961203318801526
Publication date: 2018-09-23
Outcome of membranoproliferative glomerulonephritis and C3-glomerulopathy in children and adolescents.
Author(s): Holle J, Berenberg-Goßler L, Wu K, Beringer O, Kropp F, Müller D, Thumfart J
Source: Pediatr Nephrol 2018 Sep 20;
Publication date: 2018-09-20
An update on LDL apheresis for nephrotic syndrome.
Author(s): Raina R, Krishnappa V
Source: Pediatr Nephrol 2018 Sep 14;
Publication date: 2018-09-14
Risk factors for early B cell recovery following single-dose rituximab therapy in Japanese children with steroid-dependent nephrotic syndrome.
Author(s): Fujinaga S, Nishino T
Source: Pediatr Nephrol 2018 Sep 8;
Publication date: 2018-09-8
Association of infections and venous thromboembolism in hospitalized children with nephrotic syndrome.
Author(s): Carpenter SL, Goldman J, Sherman AK, Selewski DT, Kallash M, Tran CL, Seamon M, Katsoufis C, Ashoor I, Hernandez J, Supe-Markovina K, D'alessandri-Silva C, DeJesus-Gonzalez N, Vasylyeva TL, Formeck C, Woll C, Gbadegesin R, Geier P, Devarajan P, Smoyer WE, Kerlin BA, Rheault MN
Source: Pediatr Nephrol 2018 Sep 7;
Publication date: 2018-09-7
Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Author(s): Yadav M, Sinha A, Khandelwal P, Hari P, Bagga A
Source: Pediatr Nephrol 2018 Sep 7;
Publication date: 2018-09-7
B-cell therapy in lupus nephritis: an overview.
Author(s): Almaani S, Rovin BH
Source: Nephrol Dial Transplant 2018 Aug 27;
Publication date: 2018-08-27
HLA class II alleles differing by a single amino acid associate with clinical phenotype and outcome in patients with primary membranous nephropathy.
Author(s): Wang HY, Cui Z, Xie LJ, Zhang LJ, Pei ZY, Chen FJ, Qu Z, Huang J, Zhang YM, Wang X, Wang F, Meng LQ, Cheng XY, Liu G, Zhou XJ, Zhang H, Debiec H, Ronco P, Zhao MH
Source: Kidney Int 2018 Aug 26;
Publication date: 2018-08-26
Alkylating histone deacetylase inhibitors may have therapeutic value in experimental myeloperoxidase-ANCA vasculitis.
Author(s): Dooley D, van Timmeren MM, O'Reilly VP, Brady G, O'Brien EC, Fazekas B, Hickey FB, Leacy E, Pusey CD, Tam FWK, Mehrling T, Heeringa P, Little MA
Source: Kidney Int 2018 Aug 26;
Publication date: 2018-08-26
Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry.
Author(s): Hruskova Z, Pippias M, Stel VS, Abad-Díez JM, Benítez Sánchez M, Caskey FJ, Collart F, De Meester J, Finne P, Heaf JG, Magaz A, Palsson R, Reisæter AV, Salama AD, Segelmark M, Traynor JP, Massy ZA, Jager KJ, Tesar V
Source: Am J Kidney Dis 2018 Aug 16;
Publication date: 2018-08-16
Initial prednisolone dosing for the first relapse of steroid-sensitive nephrotic syndrome in Japanese children.
Author(s): Fujinaga S, Sakuraya K
Source: Pediatr Nephrol 2018 Aug 21;
Publication date: 2018-08-21
Peripheral Blood B Cell Depletion after Rituximab and Complete Response in Lupus Nephritis.
Author(s): Gomez Mendez LM, Cascino MD, Garg J, Katsumoto TR, Brakeman P, Dall'Era M, Looney RJ, Rovin B, Dragone L, Brunetta P
Source: Clin J Am Soc Nephrol 2018 Aug 8;
Publication date: 2018-08-8
A prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy.
Author(s): De Rosa M, Azzato F, Toblli JE, De Rosa G, Fuentes F, Nagaraja HN, Nash R, Rovin BH
Source: Kidney Int 2018 Jul 20;
Publication date: 2018-07-20
Mercury Intoxication as a Rare Cause of Membranous Nephropathy in a Child.
Author(s): Onwuzuligbo O, Hendricks AR, Hassler J, Domanski K, Goto C, Wolf MTF
Source: Am J Kidney Dis 2018 Jul 21;
Publication date: 2018-07-21
Complications of Immunosuppression in Glomerular Disease.
Author(s): Jefferson JA
Source: Clin J Am Soc Nephrol 2018 Jul 24;
Publication date: 2018-07-24
Insights into the Role of Mucosal Immunity in IgA Nephropathy.
Author(s): Zhang YM, Zhang H
Source: Clin J Am Soc Nephrol 2018 Jul 31;
Publication date: 2018-07-31
IgA Nephropathy Susceptibility Loci and Disease Progression.
Author(s): Shi M, Ouyang Y, Yang M, Yang M, Zhang X, Huang W, Wang W, Wang Z, Zhang W, Chen X, Pan X, Ren H, Chen N, Xie J
Source: Clin J Am Soc Nephrol 2018 Jul 24;
Publication date: 2018-07-24
Mesenchymal stem cells prevent podocyte injury in lupus-prone B6.MRL-Faslpr mice via polarizing macrophage into an anti-inflammatory phenotype.
Author(s): Zhang Z, Niu L, Tang X, Feng R, Yao G, Chen W, Li W, Feng X, Chen H, Sun L
Source: Nephrol Dial Transplant 2018 Jul 5;
Publication date: 2018-07-5
Recombinant human soluble thrombomodulin attenuates anti-glomerular basement membrane glomerulonephritis in Wistar-Kyoto rats through anti-inflammatory effects.
Author(s): Tachibana S, Iyoda M, Matsumoto K, Wada Y, Suzuki T, Iseri K, Kanazawa N, Shibata T
Source: Nephrol Dial Transplant 2018 Jul 5;
Publication date: 2018-07-5
Plasma fractalkine levels are associated with renal inflammation and outcomes in immunoglobulin A nephropathy.
Author(s): Luo R, Guo SM, Li YQ, Yang Y, Li ML, Han M, He XF, Ge SW, Xu G
Source: Nephrol Dial Transplant 2018 Jul 12;
Publication date: 2018-07-12
Acute kidney injury complicating nephrotic syndrome of minimal change disease.
Author(s): Meyrier A, Niaudet P
Source: Kidney Int 2018 Jul 3;
Publication date: 2018-07-3
Immune gene expression in kidney biopsies of lupus nephritis patients at diagnosis and at renal flare.
Author(s): Mejia-Vilet JM, Parikh SV, Song H, Fadda P, Shapiro JP, Ayoub I, Yu L, Zhang J, Uribe-Uribe N, Rovin BH
Source: Nephrol Dial Transplant 2018 May 25;
Publication date: 2018-05-25
Omics studies for comprehensive understanding of immunoglobulin A nephropathy: state-of-the-art and future directions.
Author(s): Schena FP, Serino G, Sallustio F, Falchi M, Cox SN
Source: Nephrol Dial Transplant 2018 Jun 13;
Publication date: 2018-06-13
OX40 ligand is inhibitory during the effector phase of crescentic glomerulonephritis.
Author(s): Odobasic D, Ruth AJ, Oudin V, Kitching AR, Holdsworth SR
Source: Nephrol Dial Transplant 2018 Jun 22;
Publication date: 2018-06-22
Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.
Author(s): Noris M, Donadelli R, Remuzzi G
Source: Pediatr Nephrol 2018 Jun 9;
Publication date: 2018-06-9
Efficacy of Rituximab vs Tacrolimus in Pediatric Corticosteroid-Dependent Nephrotic Syndrome: A Randomized Clinical Trial.
Author(s): Basu B, Sander A, Roy B, Preussler S, Barua S, Mahapatra TKS, Schaefer F
Source: JAMA Pediatr 2018 Jun 18;
Publication date: 2018-06-18
Transethnic, Genome-Wide Analysis Reveals Immune-Related Risk Alleles and Phenotypic Correlates in Pediatric Steroid-Sensitive Nephrotic Syndrome.
Author(s): Debiec H, Dossier C, Letouzé E, Gillies CE, Vivarelli M, Putler RK, Ars E, Jacqz-Aigrain E, Elie V, Colucci M, Debette S, Amouyel P, Elalaoui SC, Sefiani A, Dubois V, Simon T, Kretzler M, Ballarin J, Emma F, Sampson MG, Deschênes G, Ronco P
Source: J Am Soc Nephrol 2018 Jun 14;
Publication date: 2018-06-14
Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders.
Author(s): Higgins L, Nasr SH, Said SM, Kapoor P, Dingli D, King RL, Rajkumar SV, Kyle RA, Kourelis T, Gertz MA, Dispenzieri A, Lacy MQ, Buadi FK, Ansell SM, Gonsalves WI, Thompson CA, Fervenza FC, Zand L, Hwa YL, Jevremovic D, Shi M, Leung N
Source: Clin J Am Soc Nephrol 2018 May 30;
Publication date: 2018-05-30
Prevention of Fatal C3 Glomerulopathy by Recombinant Complement Receptor of the Ig Superfamily.
Author(s): Wang X, Van Lookeren Campagne M, Katschke KJ Jr, Gullipalli D, Miwa T, Ueda Y, Wang Y, Palmer M, Xing G, Song WC
Source: J Am Soc Nephrol 2018 Jun 12;
Publication date: 2018-06-12
Treating the idiopathic nephrotic syndrome: are steroids the answer?
Author(s): Deschênes G, Dossier C, Hogan J
Source: Pediatr Nephrol 2018 Jun 4;
Publication date: 2018-06-4
Induction prednisone dosing for childhood nephrotic syndrome: how low should we go?
Author(s): Sibley M, Roshan A, Alshami A, Catapang M, Jöbsis JJ, Kwok T, Polderman N, Sibley J, Matsell DG, Mammen C
Source: Pediatr Nephrol 2018 May 22;
Publication date: 2018-05-22
Mycophenolate mofetil for sustained remission in nephrotic syndrome.
Author(s): Querfeld U, Weber LT
Source: Pediatr Nephrol 2018 May 11;
Publication date: 2018-05-11
Cardiovascular outcomes of Nephrotic syndrome in childhood (CVONS) study: a protocol for prospective cohort study.
Author(s): Patnaik SK, Kumar P, Bamal M, Patel S, Yadav MP, Kumar V, Sinha A, Bagga A, Kanitkar M
Source: BMC Nephrol 2018 Apr 3;19(1):81
Publication date: 2018-04-3
Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report.
Author(s): Hirashio S, Satoh A, Arima T, Mandai K, Awaya T, Oshima K, Hara S, Masaki T
Source: BMC Nephrol 2018 May 3;19(1):108
Publication date: 2018-05-3
Eculizumab as salvage therapy for recurrent monoclonal gammopathy-induced C3 glomerulopathy in a kidney allograft.
Author(s): Moog P, Jost PJ, Büttner-Herold M
Source: BMC Nephrol 2018 May 3;19(1):106
Publication date: 2018-05-3
A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits.
Author(s): Gumber R, Cohen JB, Palmer MB, Kobrin SM, Vogl DT, Wasserstein AG, Nasta SD, Bleicher MB, Bloom RD, Dember L, Cohen A, Weiss BM, Hogan JJ
Source: Kidney Int 2018 May 11;
Publication date: 2018-05-11
Circulating complement factor H-related protein 5 levels contribute to development and progression of IgA nephropathy.
Author(s): Zhu L, Guo WY, Shi SF, Liu LJ, Lv JC, Medjeral-Thomas NR, Lomax-Browne HJ, Pickering MC, Zhang H
Source: Kidney Int 2018 May 11;
Publication date: 2018-05-11
Infusion reactions associated with rituximab treatment for childhood-onset complicated nephrotic syndrome.
Author(s): Kamei K, Ogura M, Sato M, Ito S, Ishikura K
Source: Pediatric nephrology (Berlin, Germany)
Publication date: 2018-06
Rituximab versus the modified Ponticelli regimen in the treatment of primary membranous nephropathy: a Health Economic Model.
Author(s): Hamilton P, Kanigicherla D, Venning M, Brenchley P, Meads D
Source: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Publication date: 2018-03-29
Phospholipase A2 Receptor 1 Epitope Spreading at Baseline Predicts Reduced Likelihood of Remission of Membranous Nephropathy.
Author(s): Seitz-Polski B, Debiec H, Rousseau A, Dahan K, Zaghrini C, Payré C, Esnault VLM, Lambeau G, Ronco P
Source: Journal of the American Society of Nephrology : JASN
Publication date: 2018-02
Defective gene expression of the membrane complement inhibitor CD46 in patients with progressive immunoglobulin A nephropathy.
Author(s): Coppo R, Peruzzi L, Loiacono E, Bergallo M, Krutova A, Russo ML, Cocchi E, Amore A, Lundberg S, Maixnerova D, Tesar V, Perkowska-Ptasinska A, Durlik M, Goumenos D, Gerolymos M, Galesic K, Toric L, Papagianni A, Stangou M, Mizerska-Wasia Membek M, Gesualdo L, Montemurno E, Benozzi L, Cusinato S, Hryszko T, Klinger M, Kaminska D, Krajewska M
Source: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Publication date: 2018-04-9
The lectin pathway in renal disease: old concept and new insights.
Author(s): Gaya da Costa M, Poppelaars F, Berger SP, Daha MR, Seelen MA
Source: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Publication date: 2018-04-26
Proteinase-3 and myeloperoxidase serotype in relation to demographic factors and geographic distribution in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Author(s): Weiner M, Bjørneklett R, Hrušková Z, Mackinnon B, Poulton CJ, Sindelar L, Mohammad AJ, Eriksson P, Gesualdo L, Geetha D, Crnogorac M, Jayne D, Hogan SL, Geddes C, Tesar V, Aasarød K, Segelmark M
Source: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Publication date: 2018-04-30
Urinary angiotensinogen: an indicator of active antineutrophil cytoplasmic antibody-associated glomerulonephritis.
Author(s): Wu L, Yang M, Feng X, Jin L, Wu C, Cui S, Zhou Z, Zhong X, Shi M, Yang Z, Cao W
Source: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Publication date: 2018-05-4



European Reference Networks
ERKNet is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Commission.
For more information about the ERNs and the EU health strategy, please visit http://ec.europa.eu/health/ern